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Abstract 
Mycobacterium tuberculosis is a pathogenic organism that infects a third of the world’s population and 
causes approximately 2 million deaths per year. Extensive research has been done on this pathogen, 
however our knowledge of the mechanisms of pathogenicity remain limited. The M. tuberculosis genome 
contains five ESAT-6 gene cluster regions, ESX-1 to 5, which encode specialized type VII secretion 
systems. These secretion systems are known to secrete members of the ESAT-6/CFP-10 and PE/PPE 
protein families, some of which contribute to the pathogenicity and phagosomal escape of the pathogen. 
ESX-3 has been shown to be essential for in vitro growth and survival of M. tuberculosis. The expression 
of ESX-3 in M. tuberculosis is regulated by IdeR and Zur, in response to intracellular iron and zinc 
concentrations, respectively. Interestingly, ESX-3 is not essential for the growth and survival of the 
saprophytic organism M. smegmatis.  
In this study, we aimed to identify the subcellular localisation of the individual components of the ESX-3 
secretion system in the non-pathogenic, fast-growing organism M. smegmatis. The esx conserved 
component (ecc) genes from ESX-3 were expressed from the episomal expression vector pDMNI as 
fusion proteins with green fluorescent protein (GFP). MSMEG_0615 (eccA3), MSMEG_0616 (eccB3), 
MSMEG_0623 (eccD3) and MSMEG_0626 (eccE3) were successfully cloned into pDMNI and expression 
of fusion proteins was confirmed by Western blotting for MSMEG_0615-GFP, MSMEG_0616-GFP and 
MSMEG_0626-GFP in M. smegmatis. In the M. smegmatis ESX-3 knock-out (with MSMEG_0615 to 
MSMEG_0626 deleted) expression was confirmed for MSMEG_0615-GFP and MSMEG0626-GFP. 
Fluorescent microscopy determined that MSMEG_0615-GFP localised to a single mycobacterial pole in 
both strains. MSMEG_0616-GFP and MSMEG_0626-GFP were found to be membrane associated in M. 
smegmatis, while MSMEG_0626-GFP was found to be membrane associated in the M. smegmatis ESX-3 
knock-out. 
The unipolar localisation of MSMEG_0615-GFP suggests that the assembled ESX-3 secretion system 
apparatus is situated at a single pole in M. smegmatis. Therefore, we hypothesize that MSMEG_0615 
might act as a recruiter protein that is involved in the assembly of ESX-3 at the mycobacterial pole.  
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Opsomming 
Mycobacterium tuberculosis is ‘n patogene organisme wat ‘n derde van die wêreld se bevolking infekteer 
en eis jaarliks 2 miljoen lewens deur tuberkulose. Ten spyte van uitgebreide navorsing, is daar min kennis 
oor die meganismes van patogenisiteit van hierdie organisme. Die M. tuberculosis genoom bevat vyf 
duplikasies van die ESAT-6 geen groep gebiede, ESX-1 tot 5, wat kodeer vir gespesialiseerde Tipe VII 
sekresie sisteme. Hierdie sekresie sisteme is bekend vir die sekresie van lede van die ESAT-6/CFP-10 
en PE/PPE proteïen families, waarvan sommige bydra tot die patogenisieit en fagosomale ontsnapping 
van hierdie organisme. ESX-3 is noodsaaklik vir die in vitro groei en oorlewing van M. tuberculosis. Die 
uitdrukking van ESX-3 in M. tuberculosis word gereguleer deur IdeR en Zur in reaksie op intrasellulêre 
yster en sink konsentrasies, onderskeidelik. ESX-3 word nie benodig vir die groei en oorlewing van die 
saprofitiese organisme M. smegmatis nie. 
Hierdie studie was gemik om die sub-sellulêre lokalisering van ESX-3 te identifiseer in die nie- 
patogeniese en vinnig-groeiende organisme, M. smegmatis. Die “esx conserved component” (ecc) gene 
van ESX-3 is uitgedruk vanaf die episomale uitdrukkingsvektor pDMNI as gekombineerde proteïene met 
die groen fluoreserende proteïen (GFP). MSMEG_0615 (eccA3), MSMEG_0616 (eccB3), MSMEG_0623 
(eccD3) en MSMEG_0626 (eccE3) is suksesvol gekloneer en die uitdrukking van die gekombineerde 
proteïene is bevestig deur Western oordrag vir MSMEG_0615-GFP, MSMEG_0616-GFP en 
MSMEG_0626-GFP in M. smegmatis. In die M. smegmatis ESX-3 uitklopmutant (met MSMEG_0615 tot 
MSMEG_0626 uitgeslaan) is uitdrukking bevestig vir MSMEG_0615-GFP en MSMEG0626-GFP. 
Fluoresensie mikroskopie het bepaal dat MSMEG_0615-GFP gelokaliseer is by ‘n enkele mikobakteriese 
pool in beide stamme. MSMEG_0616-GFP en MSMEG_0626-GFP was membraan-geassosieerd in M. 
smegmatis, terwyl en MSMEG_0626-GFP geassosieer het met die membraan in die M. smegmatis 
uitklopmutant. 
MSMEG_0615 het gelokaliseer by ‘n enkele pool in M. smegmatis en dit dui aan dat die saamgestelde 
ESX-3 sekresie sisteem apparaat slegs by ‘n enkele pool voorkom in M. smegmatis. Ons hipotiseer dat 
MSMEG_0615 dalk mag optree as ‘n werwer proteïen wat betrokke is by die samestelling van die ESX-3 
sekresie sisteem by die mikrobakteriese pool.  
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Problem Statement 
 
M. tuberculosis is the causative agent of tuberculosis, a disease that infects approximately a third of the 
world’s population and results in millions of deaths each year. Despite extensive research over decades 
the mechanism of pathogenicity still remains unclear. M. tuberculosis contains five ESAT-6 gene cluster 
(ESX) regions within its genome, each of which is believed to encode a type VII secretion system that is 
responsible for the secretion of proteins from within the cell. These secretion systems have been shown 
to be important for the virulence and survival M. tuberculosis. A better understanding of how and where in 
the mycobacterial membrane these secretion systems are assembled is needed. More knowledge on the 
structure, functions, regulation and substrates of these secretion systems are required to identify possible 
drug targets or vaccine candidates that could help curb the tuberculosis epidemic. 
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CHAPTER 1 
 
Introduction 
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1. Introduction 
Mycobacterium tuberculosis is a pathogenic organism that is the causative agent of tuberculosis disease 
in humans. It is estimated that a third of the world’s population is infected with M. tuberculosis and that 
approximately 2 million people annually succumb to this disease (WHO 2011). The use of the attenuated 
M. bovis bacilli Calmette-Guérin (BCG) and M. microti as vaccines has had little success in the prevention 
of disease in areas of high tuberculosis prevalence (Pym et al. 2002). These vaccine strains have a 
deletion known as the region of difference one (RD1) which has been shown to have caused the 
attenuation of these organisms (Pym et al. 2002, Brodin et al. 2002). This deletion spans part of the 
ESAT-6 gene cluster region 1 and includes the genes for the T-cell antigens CFP-10 (10 kDa culture 
filtrate protein, EsxB) and ESAT-6 (6 kDa early secreted antigenic target, EsxA) (Berthet et al. 1998).  
M. tuberculosis possesses five paralogues of the ESAT-6 gene cluster, ESX-1, -2, -3, -4, and -5 (Figure 
1.1). Interestingly, ESAT-6 gene clusters have also been identified in some high G+C Gram-positive 
Actinobacteria, such as in the closely related mycolata species which have mycolic acids in their cell wall, 
Corynebacterium and Nocardia.  However, multiple copies of these gene clusters can only be found 
within the genus Mycobacterium. (Gey van Pittius et al. 2001). ESX-4 has been identified as the ancestral 
region as its location as well as gene arrangement is the same as that of Corynebacterium diphtheria 
(Gey van Pittius et al. 2001). ESX-4 is also the smallest of the ESAT-6 gene cluster regions and contains 
the fewest genes (Gey van Pittius et al. 2001). Phylogenetic analyses have indicated that the order in 
which the ESX were duplicated is 4, 3, 1, 2 and 5 (Gey van Pittius, personal communication).  
The ESAT-6 gene clusters regions are hypothesized to encode a specialized type VII secretion system 
that exports extracellular proteins across the membrane of the mycobacteria (Abdallah et al. 2007). 
These secretion systems are commonly referred to as the ESAT-6 secretion systems or ESX secretion 
systems.  
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Figure 1.1 The five ESAT-6 gene cluster regions in M. tuberculosis H37Rv. 
The figure shows the five ESAT-6 gene cluster regions of M. tuberculosis H37Rv and their genetic 
organization. ecc is esx conserved component and esp is ESX-1 secretion-associated protein. Source: 
Bitter et al. 2009  
 
As mentioned above, M. tuberculosis contains five ESX secretion systems, ESX-1 to 5. ESX-1 is known 
to secrete the ESAT-6 and CFP-10 antigens which lack known secretion usually associated with the Tat 
and Sec secretion pathways (Berthet et al. 1998, Sorensen et al. 1995, Feltcher, Sullivan & Braunstein 
2010).  These antigens and the other genes that are situated in the RD1 deletion (in ESX-1) are required 
for the pathogenicity of the organism, as well as the cell to cell migration of M. tuberculosis and M. 
marinum (Guinn et al. 2004, Gao et al. 2004, Abdallah et al. 2006).  ESX-3 is the only gene cluster shown 
to be essential for the in vitro growth and survival of M. tuberculosis (Sassetti, Boyd & Rubin 2003). It has 
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also been shown that the expression of ESX-3 is regulated by Iron dependent repressor (IdeR) and Zinc 
uptake regulator (Zur) in response to the availability of iron and zinc, respectively (Rodriguez et al. 2002, 
Maciag et al. 2007). The most recently evolved ESX gene cluster, ESX-5, has not been shown to be 
important for in vitro growth of M. tuberculosis (Sassetti, Boyd & Rubin 2003, Sassetti, Rubin 2003). It 
has, however, been implicated in cell death and has also been shown to be required for the export of 
many proline-glutamic acid motif (PE)/ proline-proline-glutamic acid motif (PPE) family proteins in M. 
marinum and M. tuberculosis (Abdallah et al. 2006, Abdallah et al. 2011, Abdallah et al. 2009, Bottai et al. 
2012). The presence of ESX-5 is also able to distinguish between fast- and slow-growing mycobacteria 
(Gey van Pittius et al. 2006). Little is known about the functions of ESX-2 and ESX-4, but studies 
indicated that neither of these two secretion systems are required for in vitro growth or virulence (Sassetti, 
Boyd & Rubin 2003, Sassetti, Rubin 2003). It is believed that divergent evolution as well as differential 
regulation signals resulted in these ESX secretion systems having such diverse functions (Abdallah et al. 
2007).  
2. The type VII secretion system components 
The ESX loci contain a number of conserved genes that encode the core components of the type VII 
secretion system and as such these gene clusters appear to be homologues. However, some ESAT-6 
gene cluster regions encode genes that are unique to them. Comparative studies of the five different ESX 
systems in M. tuberculosis identified six genes that are present in all the ESAT-6 gene cluster regions 
and as such are hypothesized to encode the core components that make up the type VII secretion system 
and its substrates (Abdallah et al. 2007). These genes encode the following proteins: homologues of 
ESAT-6 and CFP-10, a member of the FtsK/SpoIIIE family, a subtilisin-like serine protease (mycosin), an 
integral membrane protein with 10-11 transmembrane domains and another member of the 
transmembrane protein family (Gey van Pittius et al. 2001). Aside from these six genes, all ESX gene 
clusters, except for ESX-4, possess homologues of the PE and PPE genes and these proteins, together 
with the ESAT-6 and CFP-10 homologues are predicted to be the substrates of these secretion systems. 
The conserved components EccA, -B, -C, -D and -E and the subtilisin-like serine protease, MycP (Table 
1.1), are all required for the secretion of the ESAT-6/CFP-10-like heterodimers as well as other ESX  
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Table 1.1: The core components (apart from the secretion products EsxA/EsxB and PE/PPE) of the M. tuberculosis ESX 
secretion systems. 
 
Description Gene annotation in ESAT-6 gene cluster 
 
 ESX-1 ESX-2 ESX-3 ESX-4 ESX-5 
EccA AAA+ class ATPases, CBXX/CFQX family, SpoVK, 
 1 x ATP/GTP-binding site 
Rv3868 Rv3884c Rv0282  Rv1798 
EccB Amino terminal transmembrane protein, 
 possible ATP/GTP binding motif 
Rv3869 Rv3895c Rv0283 Rv3450c Rv1782 
EccC DNA segregation ATPase, ftsK chromosome 
 partitioning protein, SpoIIIE, YukA,  
3 x ATP/GFP-binding sites, 2 x amino-terminal 
 transmembrane protein 
Rv3870-
Rv3871 
Rv3894c Rv0284 Rv3447c Rv1783-
Rv1784 
EccD Integral inner membrane protein, 
 binding-protein-dependent transport systems 
 inner membrane component signature, putative 
 transporter protein 
Rv3877 Rv3887c Rv0290 Rv3448 Rv1795 
EccE 2 x amino-terminal transmembrane protein Rv3882c Rv3885c Rv0292  Rv1797 
MycP Mycosin, subtilisin-like cell wall-associated serine 
protease 
Rv3883c Rv3886c Rv0291 Rv3449 Rv1796 
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substrates (Figure 1.2). ESX-4 does not have a copy of EccA or EccE but it is believed that these genes 
were incorporated with the evolution of the duplications of the other ESAT-6 gene cluster regions. These 
conserved proteins, the ESX and the PE/PPE substrates, will further be discussed in more detail. 
 
 
 
 
 
 
 
 
 
Figure 1.2. The predicted location of conserved ESX gene products within the inner mycobacterial 
membrane. 
The figure shows the hypothesized location of conserved ESX gene products within the membrane of M. 
tuberculosis where they assemble to form the type VII secretion system. The channel present in the outer 
membrane represents a hypothetical pore protein, the existence of which is unconfirmed. Source: Bitter et 
al. 2009.  
2.1 ESX secretion substrates 
Our understanding of how type VII secretion systems are assembled and how they secrete target proteins 
is largely based on work done on ESX-1. The most well known ESX-1 secreted proteins are ESAT-6 and 
CFP-10, which are secreted as a stable heterodimer (Figure 1.3 A) (Renshaw et al. 2002). CFP-10 and 
ESAT-6 are members of the WXG protein family which are approximately a 100 amino acids in length 
each, and can typically be found in pairs (Gey van Pittius et al. 2001, Renshaw et al. 2002, Pallen 2002). 
The M. tuberculosis genome contains 23 pairs of genes for ESAT-6 and CFP-10, which are located at 11 
loci and are often preceded by genes from the PE and PPE protein family (Gey van Pittius et al. 2001). 
The secretion of the ESAT-6/CFP-10 protein complex (EsxA and EsxB transcribed from the ESX-1 
region) is important for the pathogenicity of some mycobacterial species. For example: the absence of 
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ESX-1 secretion in M. bovis BCG, M. microti and M. tuberculosis H37Ra results in the attenuation of 
these strains (Pym et al. 2002, Frigui et al. 2008). Although EsxA and EsxB are required for the 
pathogenicity of the organism, the mechanism of their involvement remains unclear. Another ESX gene, 
EsxH (Rv0288) from ESX-3, has also been shown be to a strong antigen in tuberculosis patients and 
BCG vaccinated individuals (Skjot et al. 2000). Despite the diverse functional roles for each of the five 
ESAT-6 gene cluster regions, it is hypothesized that the Esx protein complexes adopt similar backbone 
topologies to the reported EsxA·EsxB complex with unique surface properties and features that determine 
their functional roles. It has been determined that the core structure of EsxG·EsxH is similar to that of 
EsxA·EsxB but that this structure might possess a specific Zn2+ binding site (Figure 1.3 B). Unlike the 
EsxA·EsxB heterodimer, there is no evidence of interaction with the surface of macrophage/monocyte-like 
cells. This suggests that EsxA·EsxB is involved in pathogen-host cell signaling and that EsxG·esxH is 
involved in iron and zinc acquisition (Ilghari et al. 2011). Other proteins that are secreted by the ESX-1 
secretion system include EspR, EspA, EspB and EspC (Feltcher, Sullivan & Braunstein 2010).  
  
Figure 1.3. The structures of the EsxA·EsxB and EsxG·EsxH complexes. 
A. A ribbon representation of the CFP-10·ESAT-6 complex with ESAT-6 in blue and CFP-10 in red. 
Source: Lightbody et al. 2008. B. A ribbon representation of the EsxG·EsxH complex. EsxG is shown in 
red and EsxH is shown in blue. Source: Ilghari et al. 2011. The images clearly show the two helix-turn-
helix hairpin structures formed by the Esx- Esx complexes and the flexible N and C termini of both 
proteins within the complexes.  
A B 
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It is hypothesized that the first PE and PPE genes were inserted into the first duplication of ESX-4 to 
ESX-3 and that they were subsequently duplicated with the other ESAT-6 gene cluster regions (Gey van 
Pittius et al. 2006). The PE and PPE protein family is unique to the mycobacteria and although the 
precise function(s) of these proteins remain(s) unknown, they have been implicated in bacterial virulence 
(Brennan et al. 2001, Li et al. 2005, Ramakrishnan, Federspiel & Falkow 2000). These PE/PPE gene 
families have expanded extensively in the slow growing and pathogenic mycobacteria. In M. marinum, 
various PPE and PE family proteins, such as PPE41 and members of the Polymorphic GC-rich-repetitive 
sequence (PE_PGRS) subfamily, are secreted in an ESX-5 dependent manner (Abdallah et al. 2006, 
Abdallah et al. 2009). ESX-5 has also been shown to be required for the secretion of PPE41 in M. 
tuberculosis and it has been shown that the PE and PPE proteins encoded by ESX-5 might be involved in 
the ESX-5 secretion machinery (Bottai et al. 2012). The ppe-pe genes are flanked by ecc (esx conserved 
components) genes that are predicted to encode membrane components and ATP-binding proteins that 
form the secretion system (Brodin et al. 2004, Bitter et al. 2009). 
2.2 ESX Conserved Component A (eccA) 
EccA is a cytoplasmic AAA ATPase from the CbxX/CfqX subfamily of AAA+ ATPases (Luthra et al. 2008). 
The AAA+ class ATPases are believed to have a wide range of functions including protein degradation, 
DNA replication, recombination, transcriptional regulation, vesicular fusion, peroxisome biogenesis and 
the assembly of membrane complexes (Snider, Houry 2008, Ogura, Whiteheart & Wilkinson 2004). In M. 
tuberculosis and M. marinum EccA is an essential component of the ESX-1 secretion system, although 
it’s exact role and functions have not been characterized. It has been found that disruption of Rv3868 
(EccA1 in M. tuberculosis) prevents the secretion of EsxA, EsxB, EspA and EspB however it does not 
affect the expression of these proteins (Luthra et al. 2008). 
AAA+ family proteins are known to form hexameric rings of homo- or hetero-oligomers (Ogura, Whiteheart 
& Wilkinson 2004). EccA1 exists as multiple hexamers with a molecular mass of 380kDa. It is believed 
that the N-terminal domain of this protein does not possess any ATPase activity and that this compact 
domain is a monomer in contrast to the hexameric association that’s observed with the full length protein. 
The C-terminal domain was found to predominantly act as a dimer in the absence of ATP; however in the 
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presence of ATP the protein forms higher order oligomers (Luthra et al. 2008). In silico methods were 
used to generate a model of the hexameric association of Rv3868 (Figure 1.4). The resulting model 
suggests that the binding pocket is lined with Pro-336, Glu-337, Thr-338, Lys-340 and Arg-429 and that 
the ATP lies in a defined area within the binding pocket in which Arg-429 is part of a neighbouring subunit 
and acts as a sensory arginine (Ogura, Whiteheart & Wilkinson 2004). This residue senses the presence 
of the nucleotide within the binding site giving rise to the associated mechanical outcomes of AAA-
ATPases (Luthra et al. 2008). 
 
Figure 1.4. The hexameric structure formed by Rv3868. 
Rv3868 forms a hexameric structure that possesses ATPase activity. The arrows indicate the predicted 
movement of the N-terminal domain. The ATP binding site is marked with a box. Source: Luthra et al. 
2008 
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It has been predicted that Rv3868 might be involved in the translocation of substrates across the 
mycobacterial membrane. Rv3868 may interact with a gating protein to specifically modulate secretion of 
virulence factors. Alternatively, Rv3868 may be involved in translocation of substrates by transferring 
energy to co-proteins of the ESX-1 secretion system. When an ATP molecule is bound to Rv3868, the 
two domains of the molecule are in close proximity, however upon the release of the nucleotide there is a 
conformational change as to make the molecule more accessible to interactions with proteins of the ESX-
1 secretion system (Luthra et al. 2008). 
It is believed that the C-terminal region of EsxB is a signal sequence that is recognized by Rv3871 and 
that this sequence targets the EsxA/EsxB heterodimer for secretion by the ESX-1 system (Champion et 
al. 2006). Another protein that has a high sequence similarity to the C-terminal region of EsxB is EspC 
(Rv3615c). These two proteins share conserved regions in the last 25 amino acids but have divergent 
signal sequences that indicate different targeting sequences for these two substrates. It has been shown 
that the two signal sequences are both required for ESX-1 secretion and that the EspC signal sequence 
is not functionally equivalent to the EsxB signal sequence (DiGiuseppe Champion et al. 2009).  It was 
determined through yeast two-hybrid studies that EspC interacted with Rv3868 and that ExsB failed to 
interact with Rv3868. Rv3868 showed no direct interactions with EsxA/EsxB proteins as well as no 
stimulation of the ATPase activity in assays (Luthra et al. 2008). This suggests that the Rv3868/EspC 
interaction is specific (DiGiuseppe Champion et al. 2009). 
EccA is thus an ATPase with a co-factor-induced “open–close” movement that allows for the secretion of 
the EsxA/EsxB heterodimer (Figure 1.4), possibly by providing energy to other proteins of the ESX-1 
secretion machinery, such as EspE in order to secrete the EsxA/EsxB complex (Luthra et al. 2008, 
DiGiuseppe Champion et al. 2009).  
2.3 EccB 
EccB is a possible amino terminal transmembrane protein with a ATP/GTP binding motif. It has been 
established that interruption of Rv3869, the EccB from ESX-1 results in the loss of EsxA/EsxB secretion 
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despite normal expression of these two virulence factors (Brodin et al. 2006). No further information is 
available at this stage regarding the function of EccB. 
2.4 EccC 
In M. tuberculosis, EccC is an FtsK/SpoIIIE-like protein that is transcribed from one gene in ESX-4, -3 and 
2 (Rv3447c, Rv0284 and Rv3894c, respectively), but from two genes in ESX-1 and ESX-5 (Rv3870-
Rv3871 and Rv1783-Rv1784, respectively) (Figure 1.1). Members of the FtsK/SpoIIIE protein family have 
a diversity of functions that includes chromosome partitioning, conjugative transfer of plasmid DNA, and 
the export of virulence factors (Burton, Dubnau 2010). 
It is predicted that Rv3870 is an integral membrane protein and that Rv3871 is a cytoplasmic AAA 
ATPase that is required for the secretion of the EsxA/EsxB heterodimer (Feltcher, Sullivan & Braunstein 
2010). It has been determined that the 7 C-terminal residues of EsxB are required for the secretion of the 
EsxA and EsxB complex by ESX-1. A model has been proposed for the targeting of secreted substrates 
by ESX-1 in M. tuberculosis, in which the stable EsxA/EsxB heterodimer interacts with Rv3871 via the C-
terminal domain of EsxB. The substrate-bound Rv3871 interacts with Rv3870, which targets the 
EsxA/EsxB complex for secretion (Champion et al. 2006).  
2.5 EccD 
EccD is a probable multi-transmembrane spanning protein with short periplasmic and cytoplasmic loops 
that form a channel or translocation pore in the inner membrane of the mycobacterium (Feltcher, Sullivan 
& Braunstein 2010). In M. tuberculosis it is believed that Rv3877 forms a pore or a channel that can be 
used for protein translocation across the inner membrane of the organism (Feltcher, Sullivan & 
Braunstein 2010). Disruption of Rv3870, Rv3871 and Rv3877 abolishes the secretion of EsxA and EsxB 
and causes the organism to become less virulent (Stanley et al. 2003).  
2.6 EccE 
EccE (Rv3882c in ESX-1) is a possible transmembrane protein situated in the inner membrane of M. 
tuberculosis facing the periplasm (Abdallah et al. 2007). Rv3882c has been shown to interact with 
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Rv3614c (EspD), a cytosolic protein. This interaction is essential for the secretion of EsxA and EsxB 
(MacGurn et al. 2005). No further information is available at this stage regarding the function of EccE. 
2.7 Mycosin P 
Sequence analysis of the mycosins suggests that this group of proteins are membrane-anchored serine 
proteases of which each protein contains a conserved catalytic triad (Asp, His, Ser), the presence of 
which is typical of members of the subtilisin protease family. The mycosin proteases all have N-terminal 
signal sequences and C-terminal transmembrane anchors which allow them to ne anchored in the 
membrane of the organism (Brown et al. 2000, Ohol et al. 2010). The non-pathogenic organism M. 
smegmatis possesses three mycosin proteases MycP1, 2 and 3, which were shown to be localised in the 
bacterial cell wall. This data supports the hypothesis that mycosins might possess signal peptides with C-
terminal transmembrane regions (Brown et al. 2000). MycP1 is essential for ESX-1 secretion in M. 
tuberculosis and M. smegmatis (Ohol et al. 2010). 
Microbial pathogens can utilize proteases as virulence factors for a number of functions such as 
activation of regulatory proteins or peptides, inactivation of host defense molecules, acquisition of 
nutrients, tissue damage and the processing of secreted signaling molecules that regulate gene 
expression (Dave et al. 2002). 
A MycP1 knockout strain expressing a mycosin protease with a modified active site displayed increased 
secretion of EsxA, EsxB, EspA and EspR. It is believed that the increased secretion of ESX-1 substrates 
is the direct result of the loss of the protease activity of MycP1 and that MycP1 negatively regulates ESX-
1 secretion in M. smegmatis by cleaving the activator protein, EspB, which is essential for ESX-1 
secretion. It is thought that MycP1 regulates the amount of EsxA which is secreted to obtain an optimal 
balance between virulence and immunogenicity (Ohol et al. 2010), as EsxA stimulates the immune 
response. Thus over-stimulation of the immune response may suppress M. tuberculosis growth in vivo. 
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3. The ESX-3 secretion system 
All mycobacteria possess an ESX-3 gene cluster region. ESX-3 is essential for the in vitro growth and 
survival of M. tuberculosis (Sassetti, Boyd & Rubin 2003, Sassetti, Rubin 2003), however, ESX-3 was 
found to not be essential for growth in M. smegmatis (Siegrist et al. 2009). In M. tuberculosis H37Rv, the 
ESX-3 operon encompasses the genes Rv0282 to Rv0292, while in M. smegmatis the operon 
encompasses the genes MSMEG_0615 to MSMEG_0626. This region has been implicated in cation 
homeostasis and antigenicity in tuberculosis.  
 
3.1 The role of ESX-3 in metal cation homeostasis 
The availability of iron is very important for the survival of M. tuberculosis, which uses this element as a 
co-factor for enzymes that are involved in redox reactions and other essential functions(Rodriguez et al. 
2002). Due to iron not being readily available within the host organism, mycobacteria produces 
mycobactins which are high affinity iron chelators, however the amount of iron in the mycobacterial cell 
needs to be regulated as high amounts could be lethal (Rodriguez et al. 2002). Mycobacteria have four 
potential iron-dependent regulators belonging to different families: FurA and Zur (previous annotation: 
FurB) from the ferric uptake regulator (Fur) family and IdeR and SirR are members of the diphtheria toxin 
repressor (DtxR) family (Rodriguez et al. 2002, Maciag et al. 2007). 
IdeR is essential in M. tuberculosis and is an iron dependent DNA binding protein which interacts with 
specific DNA sequences called “iron-boxes” in operon regions of iron-regulated genes to control their 
expression (Gold et al. 2001, Rodriguez et al. 1999, Dussurget et al. 1999). DNA microarray studies have 
shown that 51 genes are regulated by IdeR and that all of these genes have sequences resembling iron 
boxes in their upstream regions. The identified IdeR controlled genes encode a number of proteins with 
diverse functions, these include: transporters (Rv0282, Rv0283, Rv0284), enzymes involved in lipid 
metabolism (Rv1344, Rv1345 and Rv1347) and members of the PE/PPE protein family (Rv0285, Rv0286 
and Rv2123) (Rodriguez et al. 2002). A number of these genes are situated within the ESX-3 gene 
cluster, indicating that ESX-3 is regulated by IdeR in response to the amount of iron available within the 
cell. IdeR has been shown to be responsible for iron dependent siderophore production in M. tuberculosis 
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and is required for an efficient response to oxidative stress (Rodriguez et al. 2002, Gold et al. 2001). In M. 
smegmatis IdeR was found to repress siderophore expression when bound to iron (Dussurget, Rodriguez 
& Smith 1996). 
Zinc is also an essential element for M. tuberculosis growth, and it acts as a co-factor for enzymes and 
DNA binding proteins. Zinc also serves as a structural scaffold for several other proteins (Maciag et al. 
2007). Zur is a repressor protein and within a zur mutant, genes under the transcriptional control of this 
protein are constitutively expressed (Maciag et al. 2007). This repressor protein binds a target sequence 
in the presence of zinc. DNA microarray studies identified 24 genes that were directly regulated by Zur. 
Several genes under Zur dependent transcriptional control are homologous to genes involved in zinc 
uptake in other bacteria (Maciag et al. 2007). In a M. smegmatis zur deletion mutant, plasmids with the 
following promoters of M. tuberculosis genes were found to be over-expressed: Rv0106, Rv0280, Rv0282 
and Rv2059. Rv0280 and Rv0282 are both present in ESX-3. Zur was also found to represses the 
expression of five ESAT-6 and CFP-10 like proteins from M. tuberculosis, namely esxG, esxH, esxQ, 
esxR and esxS (Maciag et al. 2007). Two of the 5 esx genes (esxG and esxH) regulated by Zur are 
located within ESX-3 and all 11 genes of ESX-3 from M. tuberculosis were upregulated in the zur deletion 
mutant, which suggests they are in an operon (Maciag et al. 2007).  
It would thus appear that the promoter upstream of ESX-3 in M. tuberculosis is regulated by both Zur and 
IdeR proteins. In M. smegmatis, ESX-3 only responds to iron and not to zinc (Maciag et al. 2009). Iron 
and zinc dependent expression of ESX-3 along with the increased expression of ESX-3 genes under acid 
stress conditions support the hypothesis that ESX-3 is expressed during tuberculosis infection (Maciag et 
al. 2009).  
Mycobacteria use two classes of siderophores to acquire iron: exochelin and mycobactin (Ratledge, 
Dover 2000). Pathogenic mycobacteria only use mycobactin and the structurally related 
carboxymycobactin to acquire iron (Ratledge, Dover 2000). ESX-3 has been shown to be required for iron 
acquisition via the mycobactin pathway and survival during infection. ESX-3 is also required for the 
growth of M. bovis BCG and M. smegmatis under iron limiting conditions.  It is believed that ESX-3 is 
required for the uptake of iron-bound mycobactin (Siegrist et al. 2009). 
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In a M. tuberculosis conditional mutant, ESX-3 has been shown to be required for growth in the absence 
of iron. The growth phenotype that is observed with this conditional ESX-3 mutant can be complemented 
by additional iron and zinc or the culture filtrate from wild-type M. tuberculosis. ESX-3 is thus required for 
the optimal uptake of iron and zinc and is thus essential for the growth of the organism in 7H9 and 7H10. 
ESX-3 is responsible for the secretion of unknown factors that are required for optimal iron and zinc 
uptake and the growth of M. tuberculosis (Serafini et al. 2009).  
3.2  ESX-3 in immunogenicity and vaccine development 
The use of vaccines to combat tuberculosis infection has had little success in areas of high tuberculosis 
prevalence. Currently M. bovis BCG and M. microti are used as vaccines but they seem to provide little or 
no protection against M. tuberculosis infection (Pym et al. 2002). There is thus a desperate need for new 
effective vaccines to help against the fight with tuberculosis.  
Recently, a new potential vaccine was created by knocking out ESX-3 in M. smegmatis. This vaccine was 
called the IKE strain due to the loss of the “immune killing evasion” that was observed in mouse models 
(Sweeney et al. 2011). Mice that were infected with the IKE strain could contain the infection with an 
innate immune response, indicating that ESX-3 genes mediate an evasion of innate immune responses. 
Complementation of the IKE strain with the M. tuberculosis ESX-3 genes (rv0278 – rv0303) resulted in a 
strain, IKEPLUS, which was shown to be rapidly cleared and was unable to kill immunocompetent mice. 
This potential vaccine candidate produced a potent and long lived adaptive immune response during 
infection that resulted in reduced levels of M. tuberculosis bacilli in IKEPLUS-immunized mice (Sweeney 
et al. 2011). 
IKE and IKEPLUS strains both possess desirable properties for anti-tuberculosis vaccines. Both these 
mutants were found to be highly attenuated in mice and they rapidly induced a cytokine response. 
IKEPLUS has the added benefit of being an M. smegmatis recombinant strain that contains a cosmid with 
M. tuberculosis ESX-3 genes. These genes being present in a vaccine strain have the potential to serve 
as specific antigens which could elicit an adaptive immune response upon infection with M. tuberculosis. 
(Sweeney et al. 2011) 
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4. The Localisation of ESX secretion systems in Mycobacteria 
 
Many pathogenic bacteria possess specialized virulence associated secretion systems, for example type 
III or type IV secretion systems, which are specifically active at the bacterial poles. This implies that the 
polar localisation of virulence related protein secretion is a feature that can be associated with 
pathogenesis (Jaumouille et al. 2008). The localisation of these secretion systems to a specific 
compartment or compartments of the cell allows for site directed secretion of virulence factors or effecter 
proteins that might be important for the pathogenesis of the organism (Carlsson et al. 2009, Wirth et al. 
2012).  
 
Recently it has been shown that ESX-1 is localised at the polar region in M. marinum as well as in M. 
smegmatis (Carlsson et al. 2009). Immunofluorescent microscopy was used to identify the location of the 
Rv3864 homologue in M. marinum, MMAR_5439. Rv3864 (EspE) was shown to be an ESX-1 substrate 
of which a part remains surface associated upon secretion. It was determined that EspE localises at the 
poles (at both the old poles and the new poles), indicating that ESX-1 secretion primarily occurs at the 
poles in M. marinum (Carlsson et al. 2009). A KasB-deficient mutant strain that possesses a more 
permeable cell wall and as such allows for an anti-serum to interact with the M. marinum homologue of 
Rv3870 (EccCa1) was used to determine the localisation of this protein in the mycobacterial membrane. 
EccCa1 also localised to the poles, supporting the observation that ESX-1 localises to the bacterial poles. 
The majority of cells displayed a unipolar localisation, predominantly at the new bacterial pole (Carlsson 
et al. 2009). M. marinum forms actin tails at one of their poles upon reaching the cytosol of infected host 
cells (Stamm et al. 2003). EspE localised to the bacterial pole with actin tails, indicating that ESX-1 is 
active at the poles and that actin polymerization occurs primarily at the new bacterial poles. It is believed 
that new peptidoglycan is inserted at the new poles, making the new poles the position of active cell 
growth. Thus, ESX-1 localises to the region of active cell wall production. These findings implicate a 
functional relationship between the secretion site and active cell growth that could possibly be of general 
importance to gram positive bacteria, including the mycobacteria (Carlsson et al. 2009). 
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The use of immunofluorescent microscopy and a ∆kasB mutant strain to determine the subcellular 
localisation of ESX-1 in M. marinum does have its limitations, as a number of cytoplasmic components of 
ESX-1 cannot be visualized by making use of this method. Recently, a study was performed in which 
fluorescent protein fusions were used to determine the subcellular localisation of ESX-1 components in 
M. smegmatis. The ESX-1 proteins were fused to a yellow fluorescent protein with a penta-glycine linker 
chain to allow native folding of the N-terminal ESX-1 protein (Wirth et al. 2012). EspE from M. smegmatis 
(MSMEG_0055) and M. tuberculosis (Rv3864) were found to localize at the bacterial poles, however 
unlike the M. marinum orthologue EspE remained unsecreted in M. smegmatis. EccCb from M. 
smegmatis (MSMEG_0062) and M. tuberculosis (Rv3871) were also found to localize at the bacterial 
poles (Wirth et al. 2012). These findings indicate that the cellular proteins and signals that are necessary 
for the polar localization of the ESX-1 apparatus are conserved in M. marinum, M. smegmatis and M. 
tuberculosis (Wirth et al. 2012). The majority of cells in which the YFP-tagged proteins were expressed 
exhibited predominantly unipolar localisation. The presence of the fluorescently tagged proteins in a 
single polar focus indicated that the poles of the mycobactrial cells are functionally distinct. (Wirth et al. 
2012) 
EccCb-YFP fusions from M. smegmatis and M. tuberculosis failed to localize to the bacterial poles in a M. 
smegmatis strain that has a large ESX-1 deletion, indicating that localization of these proteins to the poles 
is specific and not an artifact of protein aggregation or expression (Wirth et al. 2012). The localization of 
these proteins to the polar regions might be dependent on the expression of the other proteins that are 
found in the ESX-1 operon. The failure of EccCb to localize to the polar regions of the cell in a M. 
smegmatis strain that possesses a deletion of EccCa showed that other proteins that are encoded from 
the ESX-1 region are also required for the localization of this protein to the polar regions of the cell. These 
findings where further supported by the observation that the expression of M. tuberculosis ESX-1 in a M. 
smegmatis ESX-1 knock-out mutant restored the polar localistion of EccCbms. This suggests that the 
ESX-1 apparatus in M. tuberculosis is recruited to the mycobacterial cell pole. The functional 
conservation of the ESX-1 secretion system also implies that the observed species-specific differences 
are due to different secreted proteins rather than differences in their secretion systems (Wirth et al. 2012). 
Unsurprisingly, M. smegmatis EsxA and EsxB YFP fusions did not localise to any regions within the cell. 
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This is expected because it is hypothesized that only structural components of the ESX secretion systems 
will localise to the polar regions of the cell (Wirth et al. 2012). 
Transposon mutagenesis screens identified non- esx1-encoded proteins that were found to be essential 
for EsxA/EsxB secretion as well as conjugal DNA transfer in M. smegmatis. These proteins are encoded 
from a three gene operon located 7 kb upstream of ESX-1, Msmeg0044-0046. These genes are known 
as saeA-C. A SaeC-YFP fusion protein was found to unipolarly localize at the polar region of the cell. 
SaeA-YFP was found to have conditional polar localisation. Polar localisation of SaeA was only observed 
when cultured in the absence of Tween-80. It is thought that the detergent properties of Tween-80 
combined with the overexpression of the fusion protein resulted in the alteration of the cell wall structure 
and as such it disturbed the localisation of the fusion protein. Tween-80 did not have any effect on any of 
the other fusion proteins.  The SaeB-YFP fusion did not show any polar localisation (Wirth et al. 2012). 
 
To determine if fusion proteins localised that the same bacterial pole, SaeC-YFP was co-expressed with 
either EspEms-TdTomato or EccCbmsTdTomato in M. smegmatis. In all cases where dual fluorescence 
was observed, these proteins co-localised to the same mycobacterial pole. The co-localisation of these 
proteins indicates that ESX-1 associated proteins as well as the structural components of this secretion 
system are transported to the same location regardless of where they are encoded (Wirth et al. 2012). 
SaeC-YFP localised to the bacterial pole even in the absence of ESX-1 core components, however 
EccCbms was unable to localise at the bacterial pole in the absence of saeC. It is believed that the defect 
in DNA transfer as well as EsxA/EsxB secretion in ∆sae strains are due to ESX-1 not being assembled or 
being assembled at a different location within the membrane. The localisation of SaeC-YFP to the polar 
regions independently of ESX-1 encoded proteins indicates that SaeC is an early recruit to the cell pole 
as well as being a recruiter for ESX-1 assembly (Wirth et al. 2012). Time lapse fluorescent microscopy 
showed that Sae-YFP localized to the old bacterial pole following cell division (Wirth et al. 2012). This 
indicates that all ESX-1 components that show polar localisation also localise at the old bacterial pole, 
due to these proteins co-localising to the same bacterial pole.  
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The unique subcellular localisation of this specialized secretion system should come as no surprise as 
macromolecular complexes are commonly found at a specific location within the cell. Examples of these 
include complexes that are involved in cell division and DNA replication (Burton, Dubnau 2010). As 
mentioned before, many pathogenic bacteria localise their specialized secretion systems at the bacterial 
poles. The mechanism whereby the protein recognizes a polar region remains unknown. It has been 
suggested that a number of proteins recognize the polar regions of the cell by membrane curvature 
(Lenarcic et al. 2009, Huang, Ramamurthi 2010, Ramamurthi 2010), although it appears that membrane 
curvature is not the answer for mycobacteria, because the majority of cells only have fluorescence at one 
of the poles, predominantly the old pole (Wirth et al. 2012). It is hypothesized that because cell wall 
synthesis occurs at this old polar region that the cell wall growth process or a component of it may 
contribute to the localisation of ESX-1. The localisation of ESX-1 to the old pole where active cell wall 
synthesis occurs, indicates that it might be involved in the generation and modification of the cell wall 
(Wirth et al. 2012). The studies which investigated the localisation of ESX-1 in M. marinum and M. 
smegmatis both indicated that ESX-1 localises to the pole where active cell wall synthesis occurs. 
However, these two studies had contradicting results as to whether ESX-1 localises at the old or new 
mycobacterial pole. Recent studies have shown that active cell wall synthesis predominantly occurs at the 
old mycobacterial pole (Aldridge et al. 2012, Flardh 2010). It might therefore be assumed that ESX-1 
localises to the old pole. However, it is possible that cell wall growth occurs at different poles in these 
different species or that the methods used to determine the localisation of ESX-1 in M. marinum was 
insufficient to determine at which mycobacterial pole this secretion system localises as no time-lapse 
microscopy was used. The inactivation of ESX-5 by a disruption in EccD5 (Rv1795) was found to affect 
the cell wall stability. This indicates that without the secretion of EsxA secretion substrates from ESX-1 
and ESX-5, the mycobacterial cell wall becomes more permeable and that these secretion systems might 
be involved in the generation of the cell wall (Bottai et al. 2012).  
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5. Conclusion 
Tuberculosis is an infectious disease that is caused by the pathogenic organism, M. tuberculosis. This 
disease causing mycobacterium possesses five ESX gene cluster regions that are associated with 
pathogenicity. It is hypothesized that these ESX gene cluster regions encode a type VII secretion system 
that exports or is involved in the export of antigenic proteins across the mycobacterial membrane. ESX-3 
has been shown to be essential for the growth and survival of M. tuberculosis, however it has been 
determined that ESX-3 is not required for survival in M. smegmatis. In this thesis we investigate the 
subcellular localisation of the esx conserved component (ecc) proteins from ESX-3 in M. smegmatis. 
Knowing the subcellular localisation of these essential proteins will increase our knowledge of this 
important secretion system and might help to develop more effective medical approaches that will deliver 
drugs to the appropriate location as to selectively interfere with the protein function.   
6. Aim and Objectives 
Aim: 
To investigate the cellular location of components of the M. smegmatis ESX-3 secretion system in M. 
smegmatis. 
Objectives: 
1. To select a number of genes of interest located in the ESX-3 secretion system of M. smegmatis, 
which could be used as surrogate markers for the determination of the localization of the assembled 
ESX-3 secretion apparatus.  
2. PCR amplification of the genes of interest. 
3. Cloning of the genes of interest into the expression vector, pDMNI.  
4. Expression of the selected ESX-3 proteins as fusion proteins with green fluorescent protein (GFP), in 
wild type M. smegmatis and in the M. smegmatis ESX-3 knock-out. 
5. Identification of the localisation of the selected ESX-3 fusion proteins in wild type M. smegmatis and 
in the M. smegmatis knock-out strain.  
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Materials and Methods 
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2.1 Bacterial strains 
Escherichia coli XL-1 Blue was used for all cloning procedures. M. smegmatis mc2155 (Snapper et al. 
1990) and a M. smegmatis mc2155 ESX-3 knock-out strain (kind gift from Mae Newton-Foot, 
Stellenbosch University) was used to express and to determine the localisation of  the esx conserved 
components (ecc) from ESX-3 in M. smegmatis. The M. smegmatis ESX-3 knock-out strain is an 
unmarked mutant with at deletion spanning from MSMEG_0615 to MSMEG_0626. 
2.2 Media and culture conditions 
Culture media compositions are described in Table 2.1. All antibiotics and supplements are described in 
Table 2.2. 
E. coli was cultured in liquid Luria-Bertani (LB) broth with shaking or on LB agar plates at 37°C overnight. 
Liquid or solid media that was used to culture E. coli contained either ampicillin (50µg/ml) or kanamycin 
(50 µg/ml) as required. LB agar underlined with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) 
and isopropyl-β-D-thiogalactopyranoside (IPTG) when required.  
M. smegmatis strains were grown in DifcoTM Middlebrook 7H9 Broth with shaking and on BBLTM Seven 
H11 Base plates at 37°C for 2-3 days. Media contained kanamycin (25 µg/ml) where appropriate. 
Bacterial strains used in this study were stored in 40% glycerol at -80°C. 
2.3 Ziehl-Neelsen staining 
Cultures of M. smegmatis were screened for contamination using Ziehl-Neelsen staining (ZN staining) as 
described by Kent and Kubica (1985). Briefly, cultures of M. smegmatis were heat fixed to microscope 
slides. Heat fixed cultures were flooded with ZN Carbol Fuschin and heated with a flame until steaming, 
followed by an incubation period of 5 minutes. Slides were rinsed with water and decolourised with 5% 
acid-alcohol solution for 2 minutes, followed by a wash step with water. Slides were counterstained using 
Methylene Blue for 1-2 minutes, rinsed with water and allowed to air dry. Reading of slides was done with 
a light microscope under a 100X oil immersion lens. Uncontaminated M. smegmatis cultures appeared as 
pink acid fast bacilli and contaminated cultures would contain blue coloured organisms.   
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Table 2.1: Media composition. 
Medium Composition Source 
Luria-Bertani broth (LB) 0.5% (w/v) Sodium chloride 
1% (w/v) Tryptone 
0.5% (w/v) Yeast extract 
 
Sigma-Aldrich 
Merck 
Merck 
Luria-Bertani agar (LB agar) 1.2% (w/v) Bacteriological agar 
0.5% (w/v) Sodium chloride 
1% (w/v) Tryptone 
0.5% (w/v) Yeast extract 
 
Merck 
Sigma-Aldrich 
Merck 
Merck 
DifcoTM Middlebrook 7H9 0.47% (w/v) Middlebrook 7H9  
supplemented with 0.5% (v/v) glycerol, 0.5% (v/v) glucose, 
0.2% (v/v) Tween-80 after autoclaving 
 
Becton Dickson (BD) 
BBLTM Seven H11 Base 1.9% (w/v) BBLTM Seven H11 Base, supplemented with 
0.5% glycerol, 0.5% (v/v) glucose, 0.2% (v/v) Tween-80 
after autoclaving 
 
Becton Dickson (BD) 
SOC 2% (v/v) Glucose 
1% (v/v) Magnesium chloride 
0.25% (w/v) Potasium chloride  
0.05% (w/v) Sodium Chloride 
2% (w/v) Tryptone 
0.5% (w/v) Yeast Extract 
Merck 
Sigma-Aldrich 
Merck 
Sigma-Aldrich 
Merck 
Merck 
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Table 2.2: Antibiotics and supplements. 
Antibiotic/Supplement Stock 
concentration 
Solvent Sterilisation Storage Supplier Working concentration 
E. coli M. smegmatis 
Ampicillin (amp) 50 mg/ml ddH2O 
 
Filtered -20°C Roche 50 µg/ml  
Kanamycin (kan) 50 mg/ml 0.9% NaCl 
solution 
 
Filtered 4°C Sigma-Aldrich 50 µg/ml 25 µg/ml 
Tetracycline (tet) 5 mg/ml Ethanol 
 
 -20°C Sigma-Aldrich 50 µg/ml  
5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside  
(X-gal) 
20 mg/ml N,N’-dimethyl 
formamide 
 -20°C Roche 100µl per 90mm plate 
Isopropyl-β-D-
thiogalactopyranoside 
(IPTG) 
0.1 M ddH2O 
 
Filtered -20°C Biosolve 100µl per 90mm plate 
Potassium Chloride (KCl) 1M ddH2O 
 
Autoclaved, 
121°C, 100kPa,  
20 min 
Room temp Merck   
Magnesium Chloride 
(MgCl2) 
1M ddH2O 
 
Filtered Room temp Sigma-Aldrich   
Glucose 1M ddH2O 
 
Filtered -20°C Merck   
Glucose 50% (v/v) ddH2O 
 
Filtered 4°C Merck  0.5% v/v 
Glycerol 50% (v/v) ddH2O 
 
Filtered 4°C Merck  0.5% v/v 
Polyoxyethylene-sorbitan 
monooleate (Tween-80) 
20% (v/v) ddH2O 
 
Filtered 4°C Sigma-Aldrich  0.2% v/v 
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2.4 Electrocompetent cells 
2.4.1 Electrocompetent E. coli 
Electrocompetent E.coli was prepared by streaking out E. coli XL-1 Blue onto LB agar plates containing 
tetracycline (50 µg/ml); plates were incubated at 37°C overnight. A single colony was picked and 
inoculated into 50 ml LB containing tetracycline (50 µg/ml) and incubated at 37°C overnight with shaking. 
Overnight cultures were inoculated into 2L of fresh antibiotic-containing medium at a temperature of 37°C 
(dilution 1:100) and grown to OD600 = 0.7 at 37°C with shaking. Cultures were placed on ice and all further 
steps were done under ice cold conditions (4°C). Cultures were centrifuged at 4000xg for 10 minutes at 
4°C. The cell pellet was washed in an equal volume to the culture volume of 10% glycerol (that was 
stored at 4°C), followed by centrifugation at 4000xg for 10 minutes at 4°C. The wash step was repeated 
and the cells were pooled in a 50 ml falcon tube, followed by centrifugation at 4000xg for 10 minutes at 
4°C. Cells were resuspended in 4 ml of 10% glycerol. Aliquots of 100 µl were prepared followed by 
freezing in liquid nitrogen and storage at -80°C.  
2.4.2 Electrocompetent M. smegmatis 
Electrocompetent M. smegmatis was prepared by inoculating M. smegmatis into DifcoTM Middlebrook 7H9 
and grown to OD600 = 0.5, at 37°C with shaking. Cultures were incubated on ice for 1 hour and all further 
steps were done under ice cold conditions. Cells were pelleted by centrifugation at 3220xg for 10 minutes 
at 4°C, followed by resuspension in 10% glycerol (stored at 4°C) equal to culture volume. The 
resuspended culture was centrifuged at 3220xg at 4°C for 10 minutes to pellet the cells. The wash step 
was repeated and cells were resuspended in ice cold 10% glycerol using a volume of 2 ml per 100 ml of 
culture. Electrocompetent M. smegmatis was freshly prepared before use.  
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2.5 DNA manipulation 
2.5.1 Primers 
The sequence information used for the design of primers was obtained from the JVCI CMR 
Mycobacterium smegmatis MC2 Genome Page (http://cmr.jcvi.org/cgi-
bin/CMR/GenomePage.cgi?org=gms). Primers were designed using Primer Premier 5.0 (PREMIER 
Biosoft International) and were ordered from Integrated DNA Technologies (IDT, through Whitehead 
Scientific). For primer sequences refer to Table 2.3. 
Cloning primers were designed to amplify the genomic region of the genes of interest, MSMEG_0615, 
MSMEG_0616, MSMEG_0617, MSMEG_0623 and MSMEG_0626 from M. smegmatis mc2155 (Figure 
2.1). Primers were designed to amplify the genes of interest in frame. A mycobacterial ribosome binding 
site (RBS) as well as a restriction enzyme cutting site for EcoRI were incorporated into the forward 
cloning primers with the exception of one primer. Due to EcoRI cutting within the amplified MSMEG_0615 
gene, MSMEG_0615 forward primer was designed to have the restriction enzyme cutting site MfeI. EcoRI 
and MfeI are isoschizomers because they generate the same overhangs upon digesting DNA. The RBS 
enables the ribosome to bind to the RNA after transcription enabling translation of the protein.  Forward 
cloning primers were HPLC purified due to their length that ranged from 53 to 56 bases. Reverse cloning 
primers were designed to have a HindIII restriction enzyme cutting site. The restriction enzyme cut sites 
allow for easy cloning from the pGEM-T Easy vector into the pDMNI vector where the genes of interest 
will be expressed as fusion proteins with GFP. 
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Table 2.3: Primer sequences. 
Primer name Sequence (5’ – 3’) Primer 
length 
Tm* Restiction 
site 
MSMEG_0615 f CAATTGTGACACTTGAGGAGGAGAGCAAAATTCTCATGGGAAGTGACACGCTTGC 55 60 MfeI 
MSMEG_0615 r AAGCTTTTGCCGGCACCGACAGTC 24 60 HindIII 
MSMEG_0616 f GAATTCTGACACTTGAGGAGGAGAGCAAAATTCTCATGACCGGCCCCGTCAAC 53 60 EcoRI 
MSMEG_0616 r AAGCTTTTCGGGAGGCCTCCATACG 25 60 HindIII 
MSMEG_0617 f GAATTCTGACACTTGAGGAGGAGAGCAAAATTCTCATGAGCCGGCTCATCTTCGAG 56 64 EcoRI 
MSMEG_0617 r AAGCTTTTCGGTATTCCCCTCCTCGG 26 64 HindIII 
MSMEG_0623 f GAATTCTGACACTTGAGGAGGAGAGCAAAATTCTCGTGCTGGCCGCCGGAGAC 53 64 EcoRI 
MSMEG_0623 r AAGCTTTCCTGTCGAGCACGAGGCTG 26 64 HindIII 
MSMEG_0626 f GAATTCTGACACTTGAGGAGGAGAGCAAAATTCTCATGACCGCCCGGATAGCG 53 60 EcoRI 
MSMEG_0626 r AAGCTTTCGCCGGATGACCCGCTT 24 60 HindIII 
MSMEG0617seq800 TGGCACGACCCCACCAT   17 56  
MSMEG0617seq1600 GCCGACATCTTCCGCCACT 19 62  
MSMEG0617seq2400 GCAAGTTGATCGCCACCAT 19 58  
MSMEG0617seq3200 AGCGACATCGCGGTCATCAA 20 62  
pDMNIseq f GGGTGGGCGAGTTTGTCCTG 20 66  
pDMNIseq r CCAGTAGTGCAAATAAATTTAAGGG 25 68  
T7 TAATACGACTCACTATAGGG 20 56  
SP6 ATTTAGGTGACACTATAG 18 48  
 *Tm was determined by: (G + C x 4) + (A + T x 2), where A, T, G and C are the number of nucleotides of the type within the primer sequence. 
Underlined - Mycobacterial ribosome binding sites within the primers are indicated by underlined regions.
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Figure 2.1. Cloning primer design
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Figure 2.2. Sequencing primers for 
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Figure 2.3. Sequencing primers for the final pDMNI expression vector
The primers pDMNIseq f and r were designed to amplify from within the pDMNI vector cross the insert. 
These primers were used to check the presence and the sequence integrity of the insert within the final 
expression vector. 
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Table 2.4: Cloning vectors. 
Vector Description Size (bp) Source/Reference 
pGEM-T easy E. coli cloning T-vector, AmpR, lacZ, oriE 3015 Promega 
CloneJet E. coli blunt or sticky end cloning vector, 
AmpR, eco417R, multiple cloning site (MCS), 
rep (pMB1) 
2974 Fermentas 
pDMNI M. smegmatis expression vector, KanR, GFP, 
oriE, oriM 
5090 Kind gift from Ros 
Chapman, UCT 
 
 
 
 
 
 
 
 
Figure 2.4: The episomal vector pDMNI. 
pDMNI is an episomal vector that were used for the overexpression of green fluorescent protein (GFP) 
fusion proteins. This vector contains an aph gene for kanamycin resistance as well as an OriE, truncated 
cap, repA and repB and a OriM. This vector also contains the mycobacterial promoter Psmyc as well as 
the GFP gene and an rrnB terminator. 
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2.5.3 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction was used to amplify the genes of interest from M. smegmatis mc2155 genomic 
DNA. M. smegmatis extracted DNA was a kind gift from N. C. Gey van Pittius, and was prepared as 
previously described (Sambrook, Fritsch & Maniatis 1989). Genes MSMEG_0616, MSMEG_0623 and 
MSMEG_0626 were amplified using FastStart Taq DNA Polymerase (Roche) with the GC-rich buffer, as 
described by the manufacturer. Amplification conditions are described in Table 2.5. Phusion High-Fidelity 
DNA Polymerase (Fermentas) was used to PCR amplify the genes MSMEG_0615 and MSMEG_0617. 
PCR master mix reactions for Phusion High Fidelity DNA polymerase reactions are described in Table 
2.6. Amplification conditions for Phusion High-Fidelity DNA Polymerase are described in Table 2.7. 
Table 2.5: PCR amplification conditions for FastStart Taq DNA polymerase. 
Temperature (°C) Time Reaction Number of Cycles 
95 5 min Activation of FastStart Taq 1 
95 30 s Template denaturation 
35 Tm* 30 s Annealing of primers 
72 1 min/kb Elongation 
72 10 min Elongation 1 
4 ∞ Storing of sample 1 
*Tm was determined by: (G + C x 4) + (A + T x 2), where A, T, G and C are the number of nucleotides of 
the type within the primer sequence.  
Table 2.6: Master mix for Phusion High-Fidelity DNA Polymerase reactions. 
 Component 50 µl reaction n* 
Water 22.5 µl n x 22.5 µl 
5X Phusion HF Buffer 10 µl n x 10 µl 
GC rich solution (Faststart) 10 µl n x 10 µl 
dNTPs 4 µl n x 4 µl 
Phusion DNA Polymerase  0.5 µl n x 0.5 µl 
F primer 0.5 µl n x 0.5 µl 
R primer 0.5 µl n x0.5 µl 
DNA 2 µl n x 2 µl 
*n is the number of samples to be PCR amplified including a negative control 
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Table 2.7: PCR amplification conditions for Phusion High-Fidelity DNA polymerase. 
Temperature (°C) Time Reaction Number of Cycles 
98 30 s 
Activation of Phusion High-Fidelity 
DNA Polymerase 
1 
98 10 s Template denaturation 
35 Tm* 30 s Annealing of primers 
72 1 min/kb Elongation 
72 10 min Elongation 1 
4 ∞ Storing of sample 1 
*Tm was determined by: (G + C x 4) + (A + T x 2), where A, T, G and C are the number of nucleotides of 
the type within the primer sequence.  
2.5.4 Agarose Gel Electrophorsis  
PCR products and restriction enzyme digests were electrophoretically fractionated at 100V on a 1.0 % 
agarose gel in TAE (40 mM tris, 20 mM acetic acid, 1 mM ethylenediamine tetra acetic acid (EDTA)) with 
ethidium bromide. Agarose gels were visualized under UV light.  
GeneRulerTM 100bp plus DNA ladder and GeneRulerTM 1kb plus DNA ladder (Fermentas) were used as 
appropriate to determine band sizes. Where appropriate, bands of the correct size were excised from the 
agarose gel and purified using the Wizard® SV Gel and PCR Cleanup Kit (Promega). 
2.5.5 Adenylation of PCR products 
The MSMEG_0617 PCR product that was amplified with Phusion High-Fidelity DNA polymerase was 
polyadenylated to allow for T-A cloning into pGEM-T Easy. The blunt end PCR products were purified 
from the reaction mixture using the Wizard® SV Gel and PCR Cleanup Kit (Promega). Hotstart Taq DNA 
polymerase (Qiagen) was used to add a single adenosine to the PCR products. For sample preparation 
mix please refer to Table 2.8. Adenylation took place in a single PCR cycle at 72°C for 25 minutes. 
Thereafter, the adenylated PCR product was purified using the using the Wizard® SV Gel and PCR 
Cleanup Kit (Promega). 
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Table 2.8: Sample preparation mix for adenylation of blunt end PCR products. 
  1 X 50 µl 
10 X buffer 5 µl 
MgCl2 4 µl 
dATP 2 µl 
Hotstart Taq 0.3 µl 
Purified Phusion PCR 
product 
25 µl 
H2O 13.7 µl 
 
2.5.6 Ligations 
Amplified PCR products were ligated into the pGEM-T Easy vector (Promega) according to the 
manufacturer’s instructions. Briefly, 1 µl of pGEM-T Easy vector, 5 µl of 2X ligation buffer, 1 µl of T4 DNA 
ligase and 3 µl of purified PCR product were incubated at 4°C overnight.  
Inserts were ligated into pDMNI using T4 DNA ligase (Promega) as per the manufacturer’s instructions. 
Inserts were ligated to 100 ng of vector at an insert:vector molar concentration of 3:1 using 3 U of T4 DNA 
ligase. Ligation reactions were incubated at 4°C, overnight.  
2.5.7 Plasmid DNA Transformations 
Electrocompetent E. coli was electrotransformed using 2 µl of cloning vector or ligation reaction at 2.5 kV, 
25 µF, 125 µFd and 200Ω using the MicroPulser® electroporator (Bio-rad). After transformation 1 ml of 
SOC (2% glucose (v/v), 2% tryptone (m/v), 0.5% yeast extract (m/v), 1% MgCl2 (v/v), 0.05% NaCl (m/v), 
0.25% KCl (v/v), pH adjusted to 7 with 10M NaOH) was added to the cells followed by an incubation 
period of 1 hour at 37°C with shaking. The transformation was plated out on LB agar supplemented with 
the appropriate antibiotic and incubated at 37°C overnight.  
Freshly made electrocompetent M. smegmatis cells were electroporated with 1 µg of final pDMNI 
construct at 2.5 kV, 25 µF, 125 µFd and a 1000Ω using a Gene Puler® electroporator (Bio-rad). After 
transformation 1 ml of DifcoTM Middlebrook 7H9 was added, followed by an incubation of 3 hours at 37°C 
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with shaking. The transformation was plated out on BBLTM Seven H11 Base plates supplemented with 
kanamycin and incubated at 37°C for 2-3 days.  
2.5.8 Restriction Enzyme Digestion 
Plasmid DNA was digested with restriction endonucleases EcoRI (Roche), HindIII (Roche) and MfeI 
(NEB), as per manufacturer’s instructions and in the optimal buffers. All restriction enzyme digestions 
were performed in a volume of 20 µl, containing 1 ug of vector DNA and 10 units of enzyme. Restriction 
enzyme digests were incubated at 37°C for 2-5 hours.  
2.5.9 Dephosphorylation of pDMNI 
pDMNI digested with EcoRI and HindIII was dephosphorylated with rAPid Alkaline Phosphatase (Roche) 
as per the manufacturer’s instructions. Briefly, 1 µg of digested vector DNA, 2 µl of rAPid Alkaline 
Phosphatase buffer (10 X), 1 µl enzyme and nuclease free water up to 20µl was incubated at 37°C for 30 
minutes, followed by the inactivation of the enzyme at 75°C for 2 minutes. 
2.6 Generation of pDMNI constructs with genes of interest 
2.6.1 Generation of pDMNI0616, pDMNI0623 and pDMNI0626 
The DNA extracted from M. smegmatis mc2 155 was used as the PCR template to amplify the genes of 
interest, MSMEG_0616, MSMEG_0623 and MSMEG_0626 using FastStart Taq DNA polymerase 
(Roche). For primer sequences and amplification conditions refer to Tables 2.3 and 2.4. Amplified genes 
of interest were separated by agarose gel electrophoresis and the PCR amplified genes of interest were 
purified using Wizard® SV Gel and PCR Cleanup Kit (Promega) followed by their subsequent ligation into 
the commercial T-vector, pGEM-T Easy. pGEM-T Easy ligation reactions were transformed into E. coli 
and transformed cells were cultured on LB agar containing ampicillin (50 µg/ml), X-gal and IPTG. For 
pGEM-T Easy transformations white colonies were picked making use of blue/white selection and PCR 
screened with the primer sets MSMEG_0615 f and r, MSMEG_0623 f and r and MSMEG_0626 f and r to 
confirm the presence of the insert. Confirmed transformations were cultured in 10 ml LB liquid media 
supplemented with ampicillin (50µg/ml) at 37°C, overnight with shaking. Plasmids were extracted using 
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Nanodrop® ND1000 Spectrophotometer (Thermo Fisher
the integrity of the insert. These constructs were named pGemT0616
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Construction of the expression vectors pDMNI0616, pDMNI0623 and pDMNI0626
PCR was used to amplify the gene of interest and subsequently clone it into the commercial vector, 
pGEM-T Easy. Restriction enzyme digests were used to excise the insert out of pGEM
amplified gene of interest was ligated into diges
 Scientific) and sequencing was 
, pGemT0623 and pGemT0626
ted episomal vector pDMNI to create the final construct.
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pGEM-T Easy constructs and the episomal vector, pDMNI were digested with the restriction 
endonuclease EcoRI followed by purification with the Wizard® SV Gel and PCR Cleanup Kit (Promega). 
Purified digests were subsequently digested with the restriction endonuclease HindIII. Restriction digests 
were separated on a 1% agarose gel and bands with the appropriate size were excised and purified using 
the Wizard® SV Gel and PCR Cleanup Kit (Promega). Purified inserts were quantified using the 
Nanodrop® ND 1000 Spectrophotometer (Thermo Fisher Scientific).  
Digested pDMNI vector was dephosphorylated with rAPid Alkaline Phosphatase (Roche). Purified inserts 
were ligated into the episomal vector pDMNI to create the final construct. pDMNI-insert ligations were 
transformed into E. coli and cultured on LB agar containing kanamycin (50 µg/ml) at 37°C, overnight. 
Colonies were PCR amplified to confirm the presence of the insert followed by the extraction of the final 
constructs with the use of Wizard® Plus SV Miniprep Plasmid Purification Kit from 10 ml E. coli cultures. 
Sequencing was done to verify the integrity of the insert in the final construct. These constructs were 
named pDMNI0616, pDMNI0623 and pDMNI0626 (Figure 2.5 and 2.6), respectively. 
 
 
 
 
 
 
 
Figure 2.6 The final constructs pDMNI0616, pDMNI0623 and pDMNI0626. 
The vector maps of the final constructs pDMNI0616, pDMNI0623 and pDMNI0626 shows the genes of 
interest having been cloned into the episomal vector pDMNI. These genes of interest will be expressed as 
fusion proteins with GFP. 
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2.6.2 Generation of pDMNI0615 
M. smegmatis mc2 155 was used as the PCR template to amplify the gene of interest, MSMEG_0615 with 
Phusion High-Fidelity DNA Polymerase. For primer sequences, sample preparation and amplification 
conditions refer to Tables 2.3, 2.5 and 2.6, respectively. The amplified product was separated by agarose 
gel electrophoresis on a 1% agarose gel, excised and purified using Wizard® SV Gel and PCR Cleanup 
Kit (Promega) followed by its subsequent ligation into the commercial CloneJET vector. 
The CloneJET ligation reaction was transformed into E. coli and subsequently cultured on LB agar plates 
containing ampicillin (50 µg/ml). Colonies were picked from the CloneJET transformation plates and PCR 
screened to confirm the presence of the insert. The plasmid was extracted using the Wizard® Plus SV 
Miniprep Plasmid Purification Kit. The purified plasmid was quantified using the Nanodrop® ND1000 
Spectrophotometer (Thermo Fisher Scientific) and sequencing was done to verify the integrity of the 
insert. This construct was named CJ0615. 
The insert was digested out of CJ0615 with the restriction endonucleases MfeI and HindIII. The restriction 
digest was separated on a 1% agarose gel and the band with the appropriate size was excised and 
purified using the Wizard® SV Gel and PCR Cleanup Kit (Promega). The purified insert was quantified 
using the Nanodrop® ND 1000 Spectrophotometer (Thermo Fisher Scientific). The insert was 
subsequently ligated into the EcoRI and HindIII digested and dephosphorilated pDMNI episomal vector. 
This pDMNI-insert ligation was transformed into E. coli and cultured on LB agar containing (50 µg/ml) at 
37°C, overnight. Colonies were PCR amplified to confirm the presence of the insert followed by the 
extraction of the final construct with the use of Wizard® Plus SV Miniprep Plasmid Purification Kit from 10 
ml E. coli cultures. Sequencing was done to verify the integrity of the insert in the final construct. This final 
construct was named pDMNI0615 (Figure 2.7). 
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Figure 2.7 The final construct pDMNI0615. 
The vector map of the final construct pDMNI0615 shows the gene of interest having been cloned into the  
episomal vector pDMNI. MSMEG_0615 will be expressed as a fusion protein with GFP. 
 
2.6.3 Generation of pGemT0617 
M. smegmatis mc2 155 was used as the PCR template to amplify the gene of interest, MSMEG_0617 with 
Phusion High-Fidelity DNA Polymerase. For primer sequences, sample preparation and amplification 
conditions refer to Tables 2.3, 2.5 and 2.6, respectively. The amplification product was separated by 
agarose gel electrophoresis on a 1% agarose gel. The PCR amplified MSMEG_0617 was purified using 
Wizard® SV Gel and PCR Cleanup Kit (Promega). The purified PCR product was adenylated to allow for 
T-A cloning with pGEM-T Easy followed by purification with the Wizard® SV Gel and PCR Cleanup Kit 
(Promega) and quantification using the Nanodrop® ND1000 Spectrophotometer (Thermo Fisher 
Scientific). The insert was subsequently ligated into the commercial T-vector, pGEM-T Easy. 
The pGEM-T Easy ligation reaction was transformed into E. coli and cultured on LB agar containing 
ampicillin (50 µg/ml), X-gal and IPTG. White colonies were selected making use of blue/white selection 
and PCR screened to confirm the presence of the insert. The confirmed transformations were cultured in 
10 ml LB liquid media containing ampicillin (50µg/ml) at 37°C, overnight with shaking. Plasmids were 
extracted using the Wizard® Plus SV Miniprep Plasmid Purification Kit. The purified plasmids were 
quantified using the Nanodrop® ND1000 Spectrophotometer (Thermo Fisher Scientific) and sequencing 
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was done with the primer set Sp6 and T7 as well as the primers MSMEG0617seq800, 
MSMEG0617seq1600, MSMEG0617seq2400 and MSMEG0617seq3200 to verify the integrity of the 
insert. This construct was named pGemT0617. 
2.7 In silico transmembrane structure analysis of the ESX-3 components of M. smegmatis 
In silico analyses were used to predict the structure of the proteins encoded by the genes of interest 
located in ESX-3. Protein sequence data was obtained from the JVCI CMR Mycobacterium smegmatis 
MC3 Genome Page (http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi?org=gms) and subjected to the 
TMHMM Server v2.0 transmembrane prediction analysis (TMHMM, 
http://www.cbs.dtu.dk/services/TMHMM/) to determine the transmembrane structure of the ESX-3 
components. Proteins sequence data was subsequently subjected to the SignalP server (SignalP 4.0 
Server, http://www.cbs.dtu.dk/services/SignalP/) to discriminate between signal peptides and 
transmembrane regions (Petersen et al. 2011). 
2.8 Expression of GFP tagged proteins in M. smegmatis 
2.8.1 Transformation of the expression vectors into M. smegmatis 
Electrocompetent wild type and ESX-3 knock-out strains of M. smegmatis were transformed with 1 µg of 
the final constructs, pDMNI, pDMNI0615, pDMNI0616, pDMNI0623 and pDMNI0626. These 
transformations were cultured on Middlebrook 7H11 plates containing kanamycin (25 µg/ml) at 37°C for 3 
to 4 days. Transformations were confirmed by PCR.  
2.8.2 Whole cell lysate preparation 
Whole cell lysates were prepared from M. smegmatis and M. smegmatis ESX-3 knockout cultures that 
contained the episomal vectors pDMNI, pDMNI0615, pDMNI0616, pDMNI0623 and pDMNI0626. Cultures 
of 50 ml were grown to an OD600 = 0.6 – 0.8. Cultures were spun down in 50 ml conical tubes at 3220xg 
for 10 minutes at 4°C. The cell pellet was resuspended in 500 µl ice cold PBS containing Protease 
Inhibitor Cocktail set III (Calbiochem) and transferred to a 2 ml ribolyser tube with glass beads. The cells 
were lysed by ribolysing in a BIO 101/Servant FastPrep FP120 4 times for 20 seconds, with 1 minute 
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intervals on ice. Samples were thereafter incubated for 5 minutes on ice and centrifuged in 1.5 ml safe-
lock tubes (eppendorf) for 5 minutes at 16 873xg at 4°C. The supernatant, containing the whole cell 
lysate, was removed and stored at -80°C.  
2.8.3 Protein concentration determination 
Protein concentrations of whole cell lysates were determined spectrophotometrically (Ultrospec 4051, 
LKB Biochrom) using the Bio-Rad RC DC Protein Assay according to manufacturer’s instructions. The 
Quick StartTM Bovine Serum Albumin Standard Set (2 mg/ml) was used to generate a standard curve 
ranging from 0 mg/ml to 2 mg/ml. A standard curve was plotted according to the BSA absorbance 
readings at 595 nm and whole cell lysate concentrations were determined from the standard curve. 
2.8.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
All reagents and buffers used for SDS-PAGE are described in Table 2.9 and 2.10. Whole cell lysates 
prepared from M. smegmatis and M. smegmatis ESX-3 knock-out strains containing the constructs 
pDMNI, pDMNI0615, pDMNI0616, pDMNI0623 and pDMNI0626 were separated on 12% SDS-PAGE 
gels. 
2.8.4.1 Sample Preperation 
Five microliter of 2X SDS sample buffer (refer to Table 2.10) was added to 1µg of protein sample. The 
sample was mixed and incubated at 100°C for 5 minutes.  
2.8.4.2 Gel preparation 
The gel apparatus was assembled according to the manufacturer’s instructions (Bio-Rad). 
The separating gel was prepared according to Table 2.11 and poured into the apparatus. A layer of 
Isopropanol was added onto the surface of the separating gel to remove bubbles and level the surface of 
the gel. The separating gel was allowed 20 minutes to set and the isopropanol was poured off. The 
stacking gel was prepared according to Table 2.12 and poured over separating gel until the apparatus 
was full. The comb was inserted and the gel was allowed 20 minutes to set. 
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Table 2.9: SDS-PAGE Reagents. 
Reagent Concentration Diluent Storage Source 
10% SDS 10% (m/v) Water Room temperature Sigma-Aldrich 
20 % SDS     
EDTA 0.5 M Water Room temperature Fluka 
Bromophenol Blue 0.75% (m/v) water Room temperature Fluka 
Ammonium persulphate (APS) 15% (m/v) Water 4°C Sigma-Aldrich 
Acrylamide/bisacrylamide 30:0:8% (m/v)  4°C, dark container Bio-Rad 
TEMED N,N,N',N'-Tetramethylethylenediamine  Room temperature, dark container Sigma-Aldrich 
β-Mercaptoethanol   Room temperature, dark container 
Glycine   Room temperature Merck 
Tris tris(hydroxymethyl)aminomethane  Room temperature Merck 
Glycerol   Room temperature Merck 
 
Table 2.10: SDS-PAGE Buffers. 
Buffer Component 
Volume/Weight/ 
Concentration Diluent  Storage pH 
Separating buffer Tris 1.5 M Water 4°C pH 8.8 (adjust with HCl) 
Stacking buffer Tris 1.0 M Water 4°C pH 6.8 (adjust with HCl) 
2X Reducing SDS sample buffer Stacking buffer 3.4ml   4°C or -20°C   
Glycerol 2 ml 
SDS (20%) 3 ml 
Bromophenol Blue 500 µl 
EDTA 200 µl 
  β-Mercaptoethanol 1 ml       
Running buffer (2L) Tris 6 g Water 4°C or Room temperature 
Glycine 28.8 g 
SDS 20 ml 
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Table 2.11: Separating gel composition. 
Component 12% Separating Gel 
(2 x 0.75 mm mini-slab gels) 
Acrylamide/bisacrylamide 4.0 ml 
1.5 M Tris-HCl 2.5 ml 
10% SDS 0.1 ml 
Water 3.35 ml 
TEMED 10 µl 
APS 50 µl 
 
Table 2.12: Stacking gel composition. 
Component 3% Stacking Gel 
(4 x 0.75 mm mini-slab gels) 
Acrylamide/bisacrylamide 1.3 ml 
1.0 M Tris-HCl 1.25 ml 
10% SDS 0.1 ml 
Water 7.4 ml 
TEMED 20 µl 
APS 50 µl 
 
2.8.4.3 Electrophoresis 
Gels were placed in the running chamber and running buffer was poured into the upper and lower 
chambers of the apparatus to cover the top and the bottom of the gel. Combs were removed and 
PageRulerTM Prestained protein Ladder (Fermentas) was loaded as a molecular weight marker. Samples 
were loaded into the wells and the proteins were separated by running the gel at 120V until the dye front 
reached the end of the gel.  
 2.8.4.4 Coomassie blue staining 
SDS-PAGE gels were soaked in Coomassie blue stain for 2 hours with shaking at room temperature and 
destained overnight with destaining solution. The Coomassie blue staining and destaining solutions used 
are described in Table 2.13. 
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Table 2.13: Staining and Destaining solution for SDS-PAGE. 
Solution Component Volume/Weight 
Coomassie blue staining solution Coomassie blue 2.5 g 
Methanol 450 ml 
Water 450 ml 
Acetic Acid 100 ml 
Destaining solution Glycerol 100 ml 
Glacial Acetic Acid 375 ml 
Methanol 250 ml 
Water 4275 ml 
 
2.8.5 Western Blotting  
Buffers used for Western Blotting are described in Table 2.14. A duplicate SDS-PAGE gel was subjected 
to Western blotting using a mouse anti-GFP antibody (Invitrogen) and a goat anti-mouse horse radish 
peroxidase (HRP) conjugated antibody (Invitrogen) to confirm the expression of the fusion proteins. 
2.8.5.1 Protein transfer to nitrocellulose membrane 
Transfer buffer was used to presoak 2 Western blot pads, 2 Whatmann 3M sheets and 1 HybondC-extra 
nitrocellulose or Hybond-P PVDF membrane in a large tray. Upon the completion of electrophoresis, the 
blotting apparatus was stacked on the black side of the sandwich in transfer buffer: Western blot pad, 
Whatmann sheet, SDS-PAGE gel, nitrocellulose or PVDF membrane, Whatmann sheet and Westernblot 
blot pad. The closed sandwich was placed in the Westernblot apparatus with an ice pack and a magnetic 
stirrer bar. The apparatus was filled with ice cold transfer buffer and placed on a magnetic stirrer in the 
cold room (4°C). A 100V voltage was applied to the apparatus for 60 minutes during which the buffer 
becomes milky with bubbles when current is flowing. Thereafter the membrane was blocked with 10% 
blocking buffer overnight at 4°C. 
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Table 2.14: Western Blotting buffers. 
Buffer Composition Diluent pH Storage 
Blotting/  25 mM Tris Water pH should be 8.3,  4°C 
Transfer buffer 192 mM Glycine  do not adjust  
 20% Methanol    
TBS-T Wash Buffer 20 mM Tris Water  Room  
 137 mM NaCl   temperature 
 Tween-80    
Blocking Buffer 10% m/v fat free milk powder TBS-T  Room  
 1% m/v Bovine serum albumin   temperature 
 10 mM Azide    
 
2.8.5.2 Western detection 
The blocked membrane was rinsed twice with TBS-T buffer and washed three times for 10 minutes by 
shaking in TBS-T buffer. The blocked membrane was incubated with 20 ml the primary antibody, a mouse 
anti-GFP antibody (Invitrogen) (1:500 dilution with TBS-T buffer) for 1 hour at room temperature, with 
shaking. The membrane was rinsed twice with TBS-T buffer and washed three times for 10 minutes with 
shaking in TBS-T buffer.  The membrane was subsequently incubated with 20ml secondary antibody, a 
goat anti-mouse HRP conjugated antibody (Invitrogen) (1:2000 dilution with TBS-T buffer) for 1 hour at 
room temperature with shaking.  The membrane was rinsed twice with TBS-T buffer, followed by washing 
with TBS-T buffer for 10 minutes by shaking at room temperature. The membrane was placed in a 
sealable plastic bag. 
The membrane was incubated with ECL detection fluid (ECL Plus Western Blotting Detection System, 
AmershamTM) in a dark room according to manufacturer’s instructions. Once the detection fluid was 
drained from the sealable plastic bag, the membrane was placed in an X-ray cassette. Signal was 
detected for 10-30 seconds with autoradiographic film. 
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2.9 Localisation of ESX-3 components in M. smegmatis and M. smegmatis ESX-3 knock-out 
2.9.1 Fluorescent microscopy 
Fluorescent microscopy was done at the Imaging Unit of the Central Analytical Facility at Stellenbosch 
University (http://academic.sun.ac.za/saf/services/services6_b.html).  
Fluorescent microscopy was used to determine the sub-cellular localization of the ESX-3 components 
expressed from the final constructs in wild type and ESX-3 knock-out strains of M. smegmatis. Cells were 
scored as having 1 fluorescent focus, multiple foci, membrane associated fluorescence, diffuse 
fluorescence or no fluorescence. Images were acquired on an Olympus Cell^R system attached to an 
IX81 inverted fluorescence microscope equipped with an F-view-II cooled CCD camera (Soft Imaging 
Systems). A Xenon-Arc burner (Olympus Biosystems GMBH) as was used as a light source. Images were 
acquired using a 470 nm excitation filter and emission was collected with a UBG triple-bandpass emission 
filter cube (Chroma). 
Wild type and ESX-3 knock-out strains of M. smegmatis were grown to an OD600=0.7. Ten microliters of 
cultures were placed in Lab-tek Chambered #1.0 Borosilicate Coverglass systems (eight chamber) 
(Amersham). An Olympus UPlanSApo 100x/1.4 oil objective was used to acquire images and Cell^R 
imaging software was used to process the images and to subtract the background. A light intensity of 
32,29% was used to excite the GFP.   
2.9.2 Transmission electron microscopy 
Transmission electron microscopy was performed at the Electron Microscopy Unit at the University of 
Cape Town. All sample buffers are described in Table 2.15. 
M. smegmatis wild type and ESX-3 knock-out cultures transformed with the final constructs pDMNI0615, 
pDMNI0616 and pDMNI0626 were analyzed using transmission electron microscopy (TEM). Cultures 
were grown to an OD600=0.7 and spun down at 3220xg for ten minutes at 4°C. Cells were washed with 1 
X PBS, pH7.4 and resuspended in 1 ml 1 X PBS. The cell pellet was spun down at 1377xg for 10 minutes 
and the supernatant removed. The cell pellets were resuspended in a volume of 20 times greater than 
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that of the pellet with freshly prepared TEM fixative. Cells were fixed for 2 hours at 4°C followed by 
centrifugation at 1377xg for 10 minutes. The fixed cells were resuspended in 1 ml 1X PBS and stored 
overnight at 4°C. Fixed cells were centrifuged at 1377xg for 2 minutes and washed with water, the wash 
step was repeated. The cell pellets were embedded in 2.5% low melting agarose followed by series of 
dehydration steps for 10 min with different concentrations of ethanol (30%. 50%, 70%, 80%, 90% and 
100%). Cells were incubated in a 1:1 LR white resin and 100% ethanol solution for 1 hour before being 
embedded in LR white resin. Samples were sectioned at the Electron Microscope unit at the University of 
Cape Town on a Leica EM UC7 ultramicrotome (Leica Microsystems). Samples were cut into 120 nm thin 
sections with a diamond knife. Sections were collected on formvar coated nickel grids and were allowed 
to dry overnight.  The nickel grids were incubated on a 0.1M Glycine solution for 20 minutes to quench 
free aldehyde groups and were washed twice with TBS-Tween for 2 minutes. Sections were incubated for 
30 minutes with blocking buffer followed by 2 hour incubation with the primary antibody (1:50 dilution), a 
mouse anti-GFP antibody, at room temperature. The sections were washed six times for 2 minutes with 
TBS-Tween and subsequently incubated with the secondary antibody (1:50 dilution), an anti-mouse IgG 
(whole molecule) gold conjugated antibody, for 1 hour at room temperature. Sections were washed six 
times for two minutes with TBS-Tween. Post-fixation of sections occurred on droplets of 2% 
gluteraldehyde in 0.1M phosphate buffer for 10 minutes followed by six wash steps of 2 minutes with 
TBS-Tween. Sections were rinsed with distilled water and subsequently stained with uranyl acetate for 10 
minutes, followed by staining with lead citrate for 5 minutes before being viewed on a FEI Tecnai TF20 
transmission electron microscope (FEI) fitted with a 4kX4k Gatan CCD camera. Images were collected 
and saved in dm3 format before being converted to jpg images. 
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Table 2.15 Transmission electron microscopy buffers. 
Buffer Component 
Volume/Weight/ 
Concentration Diluent Storage pH 
TEM Fixative 25 % Gluteraldehyde 200 µl water Room temperature pH 7.6 
 
4 % Formaldehyde 4 ml 
   
 
1 x PBS 1 ml 
   0.1 M Glycine solution Glycine 0.75 g Water Room temperature pH 7.6 
 
PBS 0.1 M 
   TBS-Tween (1 L) Tris 6.1 g Water Room temperature pH 7.6 
 
NaCl 9 g 
   
 
Tween 20 0.5 ml 
   Blocking Buffer BSA 1 g   Room temperature pH 7.6 
 
Cold Fish Gelatin 0.1 ml 
   
 
0.05 M TBS 100 ml 
   Dilution Buffer BSA 0.1 g   Room temperature   
 
0.05 M TBS 100 ml 
   
 
Tween 20 30 µl 
   2% Gluteraldehyde PBS 25 % Gluteraldehyde 4 ml   4 °C   
  0.1 M PBS 46 ml       
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CHAPTER 3 
 
 
Results 
  
Stellenbosch University  http://scholar.sun.ac.za
50 
 
3.1. Protein structure analysis of ESX-3 components in M. smegmatis 
The transmembrane structure of the proteins of interest, MSMEG_0615, MSMEG_0616, MSMEG_0617, 
MSMEG_0623 and MSMEG_0626 from ESX-3 in M. smegmatis was determined in silico, using the 
TMHMM Server v2.0 transmembrane prediction server.  
3.1.1 MSMEG_0615 (EccA)  
MSMEG_0615 is a conserved protein of 608 amino acids and is predicted to be an AAA+ ATPase that 
shows homology to the CBXX/CFQX and SpoVK family proteins. The results of the in silico analysis 
predicted that MSMEG_0615 is a cytoplasmic ATPase with no transmembrane domains that are involved 
in the secretion of ESX-3 substrates (Figure 3.1). No signal sequence was identified in the MSMEG_0615 
protein (Figure 3.2). 
 
 
 
 
 
 
 
 
Figure 3.1 MSMEG_0615 is predicted to be a cytoplasmic protein.  
The TMHMM transmembrane prediction of MSMEG_0615 indicates that this protein does not possess 
any transmembrane regions, confirming that MSMEG_0615 is a cytoplasmic protein. 
 
Stellenbosch University  http://scholar.sun.ac.za
51 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 SignalP analysis of MSMEG_0615 protein. 
The SignalP signal sequence prediction of MSMEG_0615 did not identify any signal sequences in the first 
70 amino acids of MSMEG_0615. 
 
3.1.2 MSMEG_0616 (EccB) 
MSMEG_0616 is a conserved hypothetical protein of a 518 amino acids. The results of the in silico 
analysis predict that MSMEG_0616 contains a transmembrane region at the N-terminal domain of the 
protein. It is also predicted that the C-terminal domain of the MSMEG_0616 is located on the outside of 
the mycobacterial plasma membrane (Figure 3.3). No signal sequence was identified in the 
MSMEG_0616 protein confirming that this protein does have a transmembrane region (Figure 3.4). 
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Figure 3.3 MSMEG_0616 is an N-terminal membrane-associated protein. 
The TMHMM transmembrane prediction of MSMEG_0616 indicates that this protein is an N-terminal 
transmembrane protein. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 SignalP analysis of MSMEG_0616 protein. 
The SignalP signal sequence prediction of MSMEG_0616 indicates that the first 120 amino acids of 
MSMEG_0616 does not possess a signal sequence, confirming that MSMEG_0616 has a 
transmembrane region. 
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3.1.3 MSMEG_0617 (EccC) 
MSMEG_0617 is a conserved protein of 1325 amino acids and is predicted to be an FtsK/SpoIIIE family 
protein with 3 ATP/GTP binding sites. FtsK/SpoIIIE family proteins are predicted to be DNA translocases 
that are involved in the translocation of chromosomal DNA during conjugative DNA transfer and septum 
formation (Crozat, Grainge 2010, Marquis et al. 2008). MSMEG_0617 might also be involved in providing 
energy for the translocation of ESX-3 substrates due to the 3 ATP/GTP binding sites. TMHMM also 
predicts that the C-terminal region of MSMEG_0617 is on the outside of the mycobacterial membrane 
(Figure 3.5). No signal sequence was identified in the first 200 amino acids of MSMEG_0617 protein, 
confirming that this protein does have a transmembrane region (Figure 3.6). 
 
 
 
 
 
 
 
 
Figure 3.5 MSMEG_0617 is predicted to be an N-terminal transmembrane protein. 
The TMHMM transmembrane prediction of MSMEG_0617 indicates that this protein is an N-terminal 
transmembrane protein with a possible signal sequence. 
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Figure 3.6 SignalP analysis of MSMEG_0617 protein. 
The SignalP signal sequence prediction of MSMEG_0616 indicates that the first 200 amino acids of 
MSMEG_0616 does not possess a signal sequence and that the transmembrane region identified is a 
true transmembrane region. 
 
3.1.4 MSMEG_0623 (EccD) 
MSMEG_0623 is a conserved integral membrane protein of 462 amino acids. This protein is predicted to 
have 10-11 transmembrane regions and is hypothesized to make up a membrane pore or channel 
through which ESX-3 substrates are transported to the outside of the mycobacterial membrane (Feltcher, 
Sullivan & Braunstein 2010). The TMHMM prediction shows that this protein has 10 transmembrane 
regions and that the C-terminal region of MSMEG_0623 is on the inside of the mycobacterial membrane 
(Figure 3.7), however it is possible that there are 11 transmembrane regions which will result in the C-
terminal region of MSMEG_0623 being on the outside of the mycobacterial membrane. No signal 
sequence was identified in the first 200 amino acids of the MSMEG_0623 protein, confirming that the 
transmembrane regions identified in the first 200 amino acids are not signal sequences but 
transmembrane regions (Figure 3.8). 
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Figure 3.7 MSMEG_0623 is predicted to be an integral membrane protein with 10-11 
transmembrane regions. 
The TMHMM transmembrane prediction of MSMEG_0623 indicates that this protein is an integral 
membrane protein with 10-11 transmembrane regions. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 SignalP analysis of MSMEG_0623 protein. 
The SignalP signal sequence prediction of MSMEG_0623 indicates that the first 200 amino acids of 
MSMEG_0623 do not possess a signal sequence confirming that the transmembrane regions identified 
by TMHMM are not signal sequences.  
Stellenbosch University  http://scholar.sun.ac.za
56 
 
3.1.5 MSMEG_0626 (EccE) 
MSMEG_0626 is a conserved hypothetical protein of a 309 amino acids. It is predicted that 
MSMEG_0626 has two N-terminal transmembrane regions and that the C-terminal of the protein is at the 
outside of the mycobacterial membrane (Figure 3.9). A signal sequence was identified in the first 20 
amino acids of the MSMEG_0626 protein indicating that MSMEG_0626 has only one transmembrane 
region (Figure 3.10). 
 
 
 
 
 
 
 
 
Figure 3.9 MSMEG_0626 is predicted to have two N-terminal transmembrane regions. 
The TMHMM transmembrane prediction of MSMEG_0626 indicates that this protein has two N-terminal 
transmembrane regions. 
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Figure 3.10 SignalP analysis of the MSMEG_0626 protein. 
The SignalP signal sequence prediction of MSMEG_0626 identified a signal sequence in the first 20 
amino acids, indicating that this protein has one transmembrane region. 
 
3.2 Generation of pDMNI constructs 
3.2.1 Generation of pDMNI0616, pDMNI0623 and pDMNI0626 
The genes of interest, MSMEG_0616, MSMEG_0623 and MSMEG0626, were PCR amplified from M. 
smegmatis mc2155 genomic DNA using designed primer sets. PCR products were ligated into pGEM-T 
Easy and transformed into electrocompetent E. coli. Transformants were selected on LB agar plates 
containing ampicillin, X-gal and IPTG and white colonies were PCR screened to confirm the presence of 
the inserts (Figure 3.11). These constructs were named pGemT0616, pGemT0623 and pGemT0626, 
respectively. DNA sequencing confirmed the integrity of the cloned genes. 
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Figure 3.11 Cloning of MSMEG_0616, MSMEG_0623 and MSMEG_0626 into pGEM-T Easy. 
PCR using the primer sets MSMEG_0616, MSMEG_0623 and MSMEG_0626 was done to confirm the 
presence of the inserts in pGEM-T Easy. Lane 1 contains GeneRulerTM 1 kb Plus DNA Ladder. Lanes 2, 4 
and 6 contains the PCR products amplified from the constructs pGemT0616 (1596 bp), pGemT0623 
(1428 bp) and pGemT0626 (969 bp), respectively. Lane 3, 5 and 7 contains PCR reactions with no DNA 
and the appropriate primers, as negative controls. 
 
The genes of interest were excised from the pGEM-T Easy constructs using restriction enzyme digestion 
and subsequently ligated into the episomal vector pDMNI. Electrocompetent E. coli were transformed with 
the pDMNI ligations and transformants were selected on LB agar plates containing kanamycin. Colonies 
were PCR screened with the primers pDMNIseq f and pDMNIseq r to confirm the presence of the pDMNI 
final construct (Figure 3.12). The resulting vectors were named pDMNI0616, pDMNI0623 and 
pDMNI0626, respectively. DNA sequencing confirmed the integrity of the cloned genes.  
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Figure 3.12 Cloning of MSMEG_0616, MSMEG_0623 and MSMEG_0626 into pDMNI. 
PCR using the primer set pDMNIseq was done to confirm the presence of the genes of interest in the 
episomal vector pDMNI. Lane 1 contains GeneRulerTM 1 kb Plus DNA Ladder. Lane 2, 3 and 4 contains 
the PCR amplicons from the final vectors pDMNI0616 (1596 bp), pDMNI0623 (1428 bp) and pDMNI0626 
(969 bp), respectively. Lane 5 contains the PCR amplicon from pDMNI (336 bp) as the positive control 
and lane 6 contains a PCR containing no DNA as the negative control. 
 
3.2.2 Generation of pDMNI0615 
MSMEG_0615 was PCR amplified from M. smegmatis mc2155 genomic DNA using the primer set 
MSMEG_0615. PCR amplified MSMEG_0615 was ligated into CloneJET and transformed into 
electrocompetent E. coli. The transformation was plated out onto LB agar containing ampicillin. Colonies 
were picked from CloneJET transformation plates and PCR screened with the primers MSMEG_0615 f 
and MSMEG_0615 r to confirm the presence of the insert in CloneJet (Figure 3.13). This construct was 
named CJ0615.  
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Figure 3.13 Cloning of PCR amplified MSMEG_0615 into CloneJET
PCR was done using the primer set MSMEG_0615 to confirm the presence of the insert in CloneJet. 
Lane 1 contains GeneRulerTM 100 bp Plus DNA Ladder. Lanes 2, 3, 4 and 5 contain PCR amplicons from 
the construct CJ0615. Lane 6 contains a PCR containing no DNA as a negative control.
 
MSMEG_0615 was excised out of CloneJET with the restriction enzymes 
subsequently cloned into pDMNI digested with 
transformed with the pDMNI0615 ligation and cultured on LB agar plates containing kanamycin. Colonies 
were picked and PCR screened with the primers pDMNIseq f and MSMEG
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Figure 3.14 Cloning of PCR amplified MSMEG_0615 into pDMNI. 
PCR was used to confirm the presence of MSMEG_0615 in the episomal vector pDMNI using the primers 
pDMNIseq f and MSMEG_0615 r. Lane 1 contains GeneRulerTM 100 bp Plus DNA Ladder. Lane 2 
contains the PCR amplicon from the final construct pDMNI0615. Lane 3 contains an amplification reaction 
with no DNA as the negative PCR control. 
 
3.2.3 Generation of pGemT0617 
MSMEG_0617 was PCR amplified from M. smegmatis mc2155 genomic DNA using the primer set 
MSMEG_0617. PCR products were adenylated and subsequently ligated into the pGEM-T Easy vector. 
Electrocompetent E. coli was transformed with the pGEM-T Easy construct and cultured on LB agar 
plates containing ampicillin, X-gal and IPTG. White colonies were selected and PCR screened to confirm 
the presence of the insert (Figure 3.15). Sequencing was performed to verify the sequence integrity of the 
insert, however the repeated occurance of single nucleotide polymorphisms (SNPs) in the insert was 
noted. For this reason, cloning of this gene was not continued.  
 
        1            2            3 
500 bp 
1000 bp 
2000 bp 2000 bp 
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Figure 3.15 Cloning of PCR amplified MSMEG_0617 into pGEM-T Easy. 
Colony PCR usint the primer set MSMEG_0617 was done to confirm the presence of the insert in pGEM-
T Easy in 4 colonies. Lane 1 contains GeneRulerTM 1 kb Plus DNA Ladder. Lane 2 contains a PCR 
amplicon of an insert of the incorrect size and lane 3 contains no product due to an empty vector, these 
samples were discarded. Lanes 4 and 5 contain the PCR amplicons of the constructs pGemT0617. Lane 
6 contains no DNA as a negative PCR control.  
 
3.3 Expression of GFP tagged proteins in M. smegmatis and M. smegmatis ESX-3 knock-out 
Electrocompetent M. smegmatis and M. smegmatis ESX-3 knock-out strains were transformed with final 
constructs pDMNI, pDMNI0615, pDMNI0616, pDMNI0623 and pDMNI0626. Colonies were picked from 
7H11 plates containing kanamycin and PCR screened to confirm the presence of the final constructs. 
Whole cell lysates were prepared from M. smegmatis and M. smegmatis ESX-3 knock-out strains that 
were PCR positive. Whole cell lysates were separated by SDS-PAGE based on size, in duplicate (one gel 
was stained with coomassie blue, and the other subjected to Western blotting).  
The coomassie blue stained SDS-PAGE gels of whole cell lysates from each clone showed a wide range 
of band sizes. No visible degradation of proteins was observed (not shown). 
        1          2          3          4          5         6 
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1500 bp 
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Figure 3.16 Detection of GFP-fusion proteins in M. smegmatis and in the M. smegmatis ESX-3 
knock-out by Western blotting. 
Western blotting analysis was performed to confirm the expression of GFP-tagged proteins in M. 
smegmatis wild type (A) and ESX-3 knock-out transformants (B). A: Lane 1 contains PageRulerTM 
Prestained Protein Ladder. Lane 2 contains the whole cell lysate for M. smegmatis. Lanes 3, 4, 5 and 7 
shows expression of GFP (26.9 kDa), MSMEG_0615-GFP (93.2 kDa), MSMEG_0616-GFP (80.5 kDa) 
and MSMEG_0626-GFP (60.1 kDa) fusion proteins in M. smegmatis ESX-3 knock-out. Lane 6 shows no 
expression of MSMEG_0623-GFP fusion proteins in this strain.  
A 
B 
100 kDa 
100 kDa 
70 kDa 
55 kDa 
35 kDa 
25 kDa 
70 kDa 
55 kDa 
35 kDa 
25 kDa 
26.9 kDa 
26.9 kDa 
93.2 kDa 
93.2 kDa 
80.5 kDa 
60.1 kDa 
60.1 kDa 
  1        2         3          4         5         6        7 
  1         2        3          4         5         6        7 
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B: Lane 1 contains PageRulerTM Prestained Protein Ladder. Lane 2 contains the whole cell lysate for M. 
smegmatis ESX-3 knock-out. Lanes 3, 4 and 7 shows expression of GFP (26.9 kDa), MSMEG_0615-GFP 
(93.2 kDa) and MSMEG_0626-GFP (60.1 kDa) fusion proteins in M. smegmatis ESX-3 knock-out. Lanes 
5 and 6 shows no expression of MSMEG_0616-GFP and MSMEG_0623-GFP fusion proteins in this 
strain. 
 
Western blotting was done with a mouse anti-GFP primary antibody and a HRP-conjugated goat anti-
mouse secondary antibody to detect the expression of the GFP fusion proteins (Figure 3.16). Western 
blotting confirmed the expression of MSMEG_0615-GFP and MSMEG_0626-GFP fusion proteins in wild 
type M. smegmatis and in the M. smegmatis ESX-3 knock-out strain. MSMEG_0616-GFP was found to 
be expressed in M. smegmatis, but no expression could be confirmed in the M. smegmatis ESX-3 knock-
out strain. No GFP fusion protein was detected in M. smegmatis or in the M. smegmatis ESX-3 knock-out 
strain that contained the vector pDMNI0623.  
 
3.4 The localisation of GFP-tagged ESX-3 proteins in M. smegmatis and M. smegmatis ESX-3 
knock-out 
Fluorescent microscopy and transmission electron microscopy were used to determine the localisation of 
GFP-tagged proteins in M. smegmatis and in the M. smegmatis ESX-3 knock-out.  
For the fluorescent microscopy cells were subjected to 1000x magnification and fluorescence was 
determined with a GFP filter (470 nm). Images were normalized for brightness and contrast. Cells were 
scored as having 1 fluorescent focus, multiple foci, membrane associated fluorescence, diffuse 
fluorescence or no fluorescence.  
Immunoelectron microscopy was done on thin sections of M. smegmatis wild type and M. smegmatis 
cultures transformed with the episomal vectors pDMNI0615, pDMNI0616 and pDMNI0626 embedded in 
LR white resin. Cells were viewed with a transmission electron microscope at a magnification of 25 000x. 
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3.4.1 M. smegmatis and M. smegmatis ESX-3 knock-out without a GFP expression vector 
Fluorescent microscopy determined that wild type M. smegmatis and M. smegmatis ESX-3 knock-out 
strains did not exhibit endogenous fluorescence (Figure 3.17 and 3.18). These strains were used as 
negative controls for fluorescence. In addition, immunoelectron microscopy of M. smegmatis determined 
that there was no specific binding of the primary and secondary antibodies within this organism (Figure 
3.19). This strain was used as a negative control for the transmission electron microscopy. 
3.4.2 pDMNI in M. smegmatis and M. smegmatis ESX-3 knockout 
Fluorescent microscopy determined that GFP is distributed throughout the cells in M. smegmatis and M. 
smegmatis ESX-3 knockout strains that were transformed with the episomal expression vector pDMNI 
(Figure 3.17 and 3.18). These strains were used as positive controls for fluorescence. 
3.4.3 MSMEG_0615 (EccA) in M. smegmatis and M. smegmatis ESX-3 knockout 
Fluorescent microscopy determined that the MSMEG_0615-GFP fusion protein showed polar localisation 
in M. smegmatis and the M. smegmatis ESX-3 knock-out (Figure 3.17 and 3.18). In M. smegmatis the 
majority of the cells, 95% (64/67) exhibited a unipolar localisation for the MSMEG_0615-GFP fusion 
protein. It was not determined what percentage of the M. smegmatis ESX-3 knock-out cells exhibited 
unipolar localisation of MSMEG_0615-GFP. Immunoelectron microscopy of M. smegmatis transformed 
with the episomal expression vector pDMNI0615 showed that the cytoplasmic protein EccA3 exhibits 
membrane association (Figure 3.19).  
3.4.4 MSMEG_0616 (EccB) is membrane associated in M. smegmatis and M. smegmatis ESX-3 knock-
out 
Fluorescent microscopy suggested that MSMEG_0616-GFP fusion protein was membrane associated in 
M. smegmatis (Figure 3.17). Due to the lack of expression of the MSMEG_0616-GFP fusion protein in the 
M. smegmatis ESX-3 knock-out, no fluorescence was observed (Figure 3.18). Additional immunoelectron 
microscopy of M. smegmatis expressing the fusion protein MSMEG_0616-GFP indicated that the EccB3 
protein localises to the mycobacterial cell wall (Figure 3.19). 
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3.4.1.5 MSMEG_0623 in M. smegmatis and M. smegmatis ESX-3 knock-out 
Due to the lack of expression of the MSMEG_0623-GFP fusion protein, no fluorescence was exhibited in 
M. smegmatis or in the M smegmatis ESX-3 knock-out strain (Figure 3.17 and 3.18). 
3.4.1.6 MSMEG_0626 (EccE) is membrane associated in M. smegmatis and M. smegmatis ESX-3 
knock-out 
Fluorescent microscopy suggested that the MSMEG_0626-GFP fusion protein was membrane associated 
in M. smegmatis and the M. smegmatis ESX-3 knock-out strain  (Figure 3.17 and 3.18). Immunoelectron 
microscopy of M. smegmatis expressing the fusion protein MSMEG_0626-GFP indicated that the EccE3 
protein localises to the mycobacterial cell wall (Figure 3.19).  
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Figure 3.17 Fluorescent microscopy of wild type M. smegmatis transformants. 
Representative transmission (left panel), GFP (middle) and merged (right) images of M. smegmatis 
transformants (not all images are shown). Wild type M. smegmatis show no fluorescence. M. smegmatis 
that contains the episomal expression vector pDMNI exhibits diffuse fluorescence throughout the cell. M. 
smegmatis expressing the MSMEG_0615-GFP fusion protein shows unipolar localisation in the organism. 
M. smegmatis cells expressing the fusion proteins MSMEG_0616-GFP and MSMEG_0626-GFP showed 
that these proteins localized to the mycobacterial membrane. No fluorescence was observed for M. 
smegmatis cells that contain the vector pDMNI0623. 
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Figure 3.18 Fluorescent microscopy of M. smegmatis ESX-3 knock-out transformants. 
Representative transmission (left panel), GFP (middle) and merged (right) images of M. smegmatis ESX-
3 knock-out transformants. The M. smegmatis ESX-3 knock-out strain shows no fluorescence. The M. 
smegmatis ESX-3 knock-out that contains the episomal expression vector pDMNI shows diffuse 
fluorescence throughout the cell. M. smegmatis ESX-3 knock-out expressing the MSMEG_0615-GFP 
fusion protein exhibits unipolar localisation in the organism. M. smegmatis ESX-3 knock-out cells 
expressing the fusion protein MSMEG_0626-GFP showed that this protein localized to the mycobacterial 
membrane. No fluorescence was observed for M. smegmatis ESX-3 knock-out cells that contain the 
vectors pDMNI0616 and pDMNI0623. 
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Figure 3.19 Transmission electron microscopy of M. smegmatis transformants.  
Immunolabelling was done on thin sections of wild type M. smegmatis (A) and M. smegmatis pDMNI0615 (B), pDMNI0616 (C) and pDMNI0626 
(D) transformants embedded in LR white resin. Binding of primary and secondary antibodies to GFP tagged proteins indicated with arrows. A: Wild 
type M. smegmatis shows no specific binding of antibodies and is used as a negative control. B: M. smegmatis pDMNI0615 transformant exhibits 
specific binding of antibodies, showing localisation of the cytoplasmic protein EccA3 to the mycobacterial membrane. C: M. smegmatis pDMNI0616 
exhibits specific binding of antibodies, showing localisation of EccB3 at the mycobacterial membrane. D: M. smegmatis pDMNI0626 transformant 
exhibits specific binding of the antibodies, showing membrane localisation of EccE3. 
  
A B C D 
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In this study we aimed to identify the sub-cellular location of the conserved components of the ESX-3 
secretion system in M. smegmatis by determining where the proteins from this secretion system localise 
within the mycobacterial cell. We also investigated whether the location of these proteins was retained in 
the M. smegmatis ESX-3 knock-out strain.  
We selected the native esx conserved component genes from ESX-3 to determine the location of this 
secretion system in M. smegmatis. The genes of interest were cloned into the episomal expression vector 
pDMNI and expressed as GFP fusion proteins in both the wild type M. smegmatis strain and the M. 
smegmatis ESX-3 knock-out strain. Western blot analysis confirmed the expression of these fusion 
proteins, while fluorescent microscopy and transmission electron microscopy were used to determine the 
location of these proteins within the mycobacterial cell. This study has provided novel insight as to how 
and where the ESX-3 secretion system is assembled in the mycobacterial membrane. 
4.1 EccA encoded by MSMEG_0615 
MSMEG_0615 (EccA3) was successfully expressed as a fusion protein in M. smegmatis and in the M. 
smegmatis ESX-3 knock-out strain. Fluorescent microscopy determined that this protein localized to the 
bacterial poles in both strains. The EccA3-GFP fusion protein exhibited unipolar localisation in both 
strains, indicating that the localisation is specific to a single polar region in the cell. Similarly, a previous 
study showed that ESX-1 associated proteins specifically localised to the old mycobacterial pole following 
cell division in M. smegmatis (Wirth et al. 2012). ESX-1 proteins were also found to be localised to a 
specific mycobacterial pole in M. marinum (Carlsson et al. 2009). It is believed that EccA is a hexameric 
AAA+ ATPase cytoplasmic protein from the CbxX/CfqX subfamily (Luthra et al. 2008) and previous 
studies have shown that some AAA+ ATPases are involved in the assembly of membrane complexes 
(Snider, Houry 2008). In silico analysis did not identify any transmembrane regions in the MSMEG_0615 
gene, supporting the hypothesis that EccA3 is a cytoplasmic protein. Immunoelectron microscopy of M. 
smegmatis cells expressing the EccA3-GFP fusion protein showed that this cytoplasmic protein exhibits 
association with the mycobacterial membrane. We demonstrate that this protein contains the 
translocation signals by the fact that EccA3 was translocated to the polar region in the absence of the 
other ESX-3 conserved components, as was shown in the M. smegmatis ESX-3 knock-out strain.  
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EccA possesses an ATP/GTP-binding site and could provide energy for the assembly of the secretion 
system at the polar region of mycobacterial membrane. EccA1 has been found to be essential for the 
cellular translocation and secretion of ESX-1 substrates in M. tuberculosis (Luthra et al. 2008). However, 
the impact of deleting the eccA gene on the functionality of the remaining operon was not determined.  
This is the first study to demonstrate the cellular location of EccA. Previous studies have primarily focused 
on EccCa1 and EccCb1 from the ESX-1 gene cluster and have shown that these proteins localise at the 
mycobacterial cell pole (Wirth et al. 2012). It was also established that EccCb1 did not localise to the 
mycobacterial pole in the absence of EccCa1, strengthening the hypothesis that these genes are co-
transcribed and co-translated from an ESX operon. We can thus hypothesize that EccA acts as a 
recruiter protein of the ESX secretion system to the mycobacterial pole where it is then inserted. 
Homologues of eccA are also present in ESX-1, ESX-2 and ESX-5 gene clusters but their cellular location 
remains to be determined. The ancestral region, ESX-4, does not possess an eccA homologue.  
4.2 EccB encoded by MSMEG_0616  
The fusion protein EccB3-GFP was expressed in wild type M. smegmatis, however no expression 
occurred in the M. smegmatis ESX-3 knock-out strain. Fluorescent microscopy determined that EccB3 
localised to the mycobacterial membrane in M. smegmatis. Immunoelectron microscopy of M. smegmatis 
expressing the EccB3-GFP fusion protein confirmed the membrane association. In silico analysis 
identified a tranmembrane region in the amino acid sequence of EccB3, supporting the hypothesis that 
EccB is a transmembrane protein. The absence of any polar localisation suggests that EccB may either 
be assembled into the ESX-3 secretion complex followed by diffusion into the cell membrane or that over-
expression of this protein might result in non-specific localisation.  Non-specific localisation may result 
from insufficient recruiter protein encoded by the wild type ESX-3 or the lack of co-translation of the ESX-
3 secretion system components.  
The reason for the absence of expression of EccB in the ESX-3 knock-out mutant is unknown but may be 
explained by the silencing of the psmyc promoter (upstream of the MSMEG_0616 gene) in the plasmid 
pDMNI0616. For example: a previous study has found that the hsp60 promoter causes plasmid instability 
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in M. bovis BCG. It was determined that various deletions occurred in the hsp60 promoter region during 
or directly after transformation (Al-Zarouni, Dale 2002). 
4.3 EccD encoded by MSMEG_0623 
Western blot analysis and fluorescent microscopy failed to detect expression of MSMEG_0623 as a 
fusion protein in M. smegmatis or in the M. smegmatis ESX-3 knock-out strain. In silico analysis identified 
10-11 transmembrane regions in the EccD3 protein, supporting the hypothesis that EccD is a multi-
transmembrane spanning protein that forms a channel or a translocation pore in the mycobacterial 
membrane (Feltcher, Sullivan & Braunstein 2010).The toxic effect of overexpression of this fusion protein 
may result in the inactivation of the psmyc promoter resulting in no protein being expressed. 
4.4 EccE encoded by MSMEG_0626  
MSMEG_0626 was expressed as a GFP fusion protein in wild type M. smegmatis and in the M. 
smegmatis ESX-3 knock-out strain. Fluorescent microscopy indicated that this fusion protein was 
membrane associated, as confirmed by immunoelectron microscopy of M. smegmatis. In silico analysis 
identified two transmembrane regions in the EccE3 protein of which one was shown to be a signal 
sequence. This supports the hypothesis that EccE
 
 homologues in M. tuberculosis are transmembrane 
proteins. The membrane location of this protein, in the absence of the conserved components of ESX-3 
(in the M. smegmatis ESX-3 knock-out strain), supports the notion of non-specific localisation.  
4.5 Limitations of this study 
Determining the location of a protein within a cell by generating a fusion protein with GFP has a number 
of limitations. The addition of a 26.9 kDa tag onto the selected proteins of interest may interfere with the 
protein’s function, its interactions with other proteins within the cell or its localisation. To reduce the steric 
interference that can be caused by the addition of such a large tag, a linker chain (SAGSAG) was used to 
link the protein of interest to GFP. These fusion proteins might also produce little or no fluorescence, they 
might have inconsistent localisation or the overexpression of the fusion proteins might be toxic to the cell 
(Wirth et al. 2012).  
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To determine at which pole the protein localizes following cell division, cells have to be imaged in a flow-
cell microfluidic chamber that constrains the mycobacteria to a single focal plane and supplies cells with 
fresh media throughout the experiment (Wirth et al. 2012, Aldridge et al. 2012). Due to the absence of 
appropriate equipment, fluorescent time-lapse microscopy could not be used to determine to which pole 
the EccA-GFP fusion protein localizes in M. smegmatis. 
To confirm that EccB3 and EccE3 are indeed non-specifically localised, co-localisation studies with EccA3 
tagged with a different fluorescent protein (e.g. YFP) could be done in future studies. 
4.6 Conclusion 
Macromolecular complexes which are involved in cell division and DNA replication have been shown to 
localise to specific regions within the cell. There is increasing evidence which shows that protein secretion 
systems also localise to specific regions within the cell (Burton, Dubnau 2010, Wirth et al. 2012). Type III 
and Type IV secretion systems are active at bacterial poles in Shigella and Agrobacterium, respectively 
(Jaumouille et al. 2008, Judd, Kumar & Das 2005). These findings indicate that pathogenic bacteria 
localise their virulence related secretion systems at the polar regions of the cell, it however remains 
unknown whether a specific location for virulence related secretion system is required for the 
pathogenicity of the organism.  In the mycobacterial species only ESX-1 has been shown to be localised 
at the bacterial pole, specifically the old bacterial pole where cell wall growth occurs (Carlsson et al. 2009, 
Wirth et al. 2012). In this study, we have shown that EccA from ESX-3 in M. smegmatis is also polarly 
localised. ESX-3 has been implicated in iron acquisition and it is unknown why this secretion system 
would localise to only one region within the mycobacterial cell. EccA might assemble the ESX-3 secretion 
system at the mycobacterial pole before diffusing into the rest of the membrane, explaining the non-
specific localisation that was observed with EccB and EccE. It is possible that the remaining secretion 
systems (ESX-5 and ESX-2) might also localise to a single mycobacterial pole, most probably the old 
pole. The ancestral region, ESX-4, which does not possess an eccA gene, could possibly not have a 
specific location in the mycobacterial membrane if EccA is a recruiter protein.   
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This study has demonstrated that EccA from ESX-3 is localised at a specific mycobacterial pole in M. 
smegmatis. Determining the location of the selected proteins of interest with this non-invasive method 
does have its limitations. Alternative methods with fewer limitations might be to create knock-ins with 
GFP. The linker chain and the GFP gene could be cloned into the genome of M. smegmatis on the 3’ end 
of the gene of interest using homologous recombination (Gordhan, Parish 2001). By generating a knock-
in strain the cell will be expressing the gene of interest at native levels from its original position in the 
genome, reducing the chance for toxicity issues. 
In future studies it may be possible to show that the secretion of ESX-3 substrates is also localised to a 
mycobacterial pole to provide further evidence that the ESX-3 secretion system is present and function at 
a single pole in M. smegmatis. Known substrates EsxG and EsxH from ESX-3 in M. smegmatis could be 
tagged with a fluorescent protein and fluorescent time-lapse microscopy could be used to determine if 
fluorescence occurs at the mycobacterial pole. By using a different fluorescent protein, it could be shown 
that secretion occurs at the same pole where the ESX-3 components localise. 
5.1 EccA 
To identify the pole at which EccA localizes following cell division, time-lapse microscopy should to be 
used in combination with a microfluidic chamber that constrains the mycobacterial cells to a single focal 
plane and supplies cells with fresh media throughout the experiment (Wirth et al. 2012, Aldridge et al. 
2012).  
The hypothesis that EccA might act as a recruiter protein, could be tested in vivo pull down assays to 
identify proteins which interact with EccA. Proteins identified by this method could be tagged with a 
fluorescent protein (other than GFP) to determine if these protein do require EccA to localise to the 
mycobacterial membrane by making use of a MSMEG_0615 knock-out. The tagged proteins can also be 
used to determine if they co-localise with MSMEG_0615-GFP in M. smegmatis. 
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5.2 EccB and EccE 
The non-specific membrane localisation exhibited by EccB-GFP and EccE-GFP could be attributed to 
insufficient recruiter protein being available to specifically localise the overexpressed fusion proteins. This 
could be rectified by using the tetracycline repressor system (Ehrt et al. 2005). This expression system 
allows for the induction or repression of gene expression in slow- and fast-growing mycobacterial species 
and can thus be used to create conditional mutants. Tetracycline can cross the biological membrane by 
diffusion, inducing expression of genes that have been cloned downstream of the conditional promoter. 
By not overexpressing the fusion proteins in the cell at all times, there might be enough recruiter protein 
available to specifically localise the fusion proteins, EccB-GFP and EccE-GFP at the mycobacterial 
membrane. 
5.3 EccC 
The failed cloning of MSMEG_0617 into pGEM-T Easy can be approached differently. Multiple primer 
sets can be used to PCR amplify sections of this gene which can be ligated together to form a single 
insertion fragment. This single insertion fragment can be ligated into the episomal expression vector 
pDMNI to generate the final construct pDMNI0617, which will subsequently express the fusion protein 
EccC-GFP in M. smegmatis. Fluorescent microscopy will be performed to identify the sub-cellular 
localisation the EccC-GFP in M. smegmatis and in the M. smegmatis ESX-3 knock-out.  
In the case of no expression or toxicity issues which may result from with the overexpression of such a 
large protein in M. smegmatis, smaller sections of the MSMEG_0617 gene can also be PCR amplified 
and ligated into pDMNI. The expression of smaller sections of this protein as fusions with GFP may result 
in less toxicity and may prevent the shutdown of transcription or translation of this gene fragment fusion. 
A conditional expression mutant can also be generated making use of the tetracycline repressor system. 
By not overexpressing the fusion proteins in the cell at all times, transcription and translation of the EccC-
GFP fusion protein may remain unaffected. 
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5.4 EccD 
There was no expression of EccD-GFP in M. smegmatis or in the M. smegmatis ESX-3 knock-out strain. 
By PCR amplifying the gene of interest fused with the GFP gene from within the pDMNI0623 vector, this 
insert can be cloned into the tetracycline repressor system. The conditional expressing mutant generated 
can thus be expressed in the presence of tetracycline, limiting the amount EccD-GFP constitutively 
produced in the cell. Fluorescent microscopy and transmission electron microscopy can subsequently be 
used to identify the sub-cellular localisation of EccD in M. smegmatis and in the M. smegmatis ESX-3 
knock-out strain. 
 
Determining the specific localisation of the other ESX-3 proteins might strengthen the hypothesis that this 
secretion system is localised at the mycobacterial pole in M. smegmatis. Identifying proteins that interacts 
with EccA, which has been shown to be unipolarly localised, is of great importance for the understanding 
of how this secretion system localises itself to one compartment within the cell. The proteins identified in 
these pull down experiments might be important for future drug and vaccine design that might help to 
eradicate the tuberculosis epidemic. 
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